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S2 
SUPPLEMENTARY CRYSTALLOGRAPHIC INFORMATION 
Figure S1. Structure of complex 5 in the solid state in two different projections; hydrogen atoms 
are omitted for clarity 
S3 
Figure S2. Structure of complex 11 in the solid state in two different projections; hydrogen 
atoms are omitted for clarity 
S4 
Preparation and X-ray Crystal Structure Analysis of Complex 5. 1-(5-Methylhexa-1,3-diyn-1-
yl)cyclohexan-1-ol (28.6 mg, 0.150 mmol) was added to a solution of [Cp*RuCl]4 (40.8 
mg, 0.037 mmol) in CH2Cl2 (5 mL) at -20°C. The mixture was stirred and quickly warmed 
to 25°C on a water bath, until a colour change from brown to cherry-red was observed. 
Cooling to -20°C, followed by evaporation of the volatile components at this temperature 
afforded a purple paste, which was dissolved in pentane (10 mL). The pentane solution 
was filtered while maintaining the mixture cold, and the supernatant was allowed to 
stand at -25°C. Brown crystals suitable for X-ray diffraction were collected after 3 days. 
C36 H51 Cl O2 Ru, Mr = 652.28  g · mol
-1
, orange plate, crystal size 0.148 x 0.121 x 0.040 mm
3
,
orthorhombic, space group Pbca, a = 19.930(2) Å, b = 14.4513(16) Å, c = 23.442(3) Å, V = 6751.5(13) Å
3
,
T = 200 K, Z = 8, Dcalc = 1.283  g · cm
3
,  = 0.71073 Å, (Mo-K) = 0.572 mm
-1
, Empirical absorption
correction (Tmin = 0.91, Tmax = 0.98), Bruker-AXS Kappa Mach3 APEX-II-diffractometer, 3.466 <  < 
36.481°, 259787 measured reflections, 16470 independent reflections, 8595 reflections with I > 2σ(I), Rint 





R1 = 0.053 [I > 2(I)], wR2 = 0.150, 367 parameters. H atoms riding, S = 1.010, Extinction coefficient = 
0.00057(15), residual electron density 0.7 / -1.2 e · Å
-3
. CCDC-1823583.
X-ray Crystal Structure Analysis of Complex 11: C34 H50 Cl2 O Ru2, Mr = 747.78  g · mol
-1
, orange plate,
crystal size 0.177 x 0.078 x 0.041 mm
3
, triclinic, space group P1¯, a = 9.7199(12) Å, b = 11.4333(14) Å, c =
14.5446(18) Å,  = 87.256(2)°,  = 75.124(2)°,  = 77.318(2)°, V = 1524.0(3) Å
3
, T = 100 K, Z = 2, Dcalc =
1.630  g · cm
3
,  = 0.71073 Å, (Mo-K) = 1.193 mm
-1
, Empirical absorption correction (Tmin = 0.95, Tmax
= 0.99), Bruker-AXS Kappa Mach3 APEX-II-diffractometer, 2.654 <  < 31.262°, 45434 measured 
reflections, 9843 independent reflections, 7663 reflections with I > 2σ(I), Rint = 0.129. The structure was 




 to R1 = 0.030 [I > 2(I)], wR2 =




Complex 4 and Reference Data 
1-(5-Methylhexa-1,3-diyn-1-yl)cyclohexan-1-ol. 
1
H NMR (400 MHz, CD2Cl2, RT) δ 2.65 (hept, J = 6.9
Hz, H
5











H} NMR (101 MHz, CD2Cl2) δ 86.5 (C
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Complex 4. 1-(5-Methylhexa-1,3-diyn-1-yl)cyclohexan-1-ol (8.4 mg, 0.044 mmol) was added to a solution 
of [Cp*RuCl]4 (12 mg, 0.011 mmol) in CD2Cl2 (0.5 mL) at -20°C in an NMR tube. 
The mixture was shaken and quickly warmed to 25°C on a water bath. A colour 
change from brown to cherry-red was observed. NMR spectroscopy indicates full 
conversion to the title complex. 
1
H NMR (400 MHz, CD2Cl2, RT) δ 5.20 (s, 1H, OH), 
3.10 (pseudopent, J=7 Hz 1H, H
5




), 1.78 (s, 15H, H
12
), 






H} (101 MHz, CD2Cl2) 160.4 (C
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* denotes residual resonances of un-coordinated alkyne 
 
* denotes decomposition during acquisition of the 
13




All reactions were carried out under Ar in glassware dried with a heat gun under vacuum (Schlenk line). 
The solvents were purified by distillation over the indicated drying agents and were transferred under Ar: 
THF, Et2O (Mg/anthracene), acetone (B2O3), CH2Cl2, toluene (Na/K), MeOH (Mg, stored over 3Å MS), 
DMPU (CaH2); DMF, CH3CN, NEt3 and pyridine were dried by an adsorption solvent purification system 
based on molecular sieves. Thin layer chromatography (TLC): Macherey-Nagel precoated plates 
(POLYGRAM
®
SIL/UV254); Flash chromatography: Merck silica gel 60 (40-63 μm or 15-40 μm (fine)) with 
pre-distilled or HPLC grade solvents. NMR: Spectra were recorded on a Bruker AV 400, AV 500 or AV 
600 spectrometer in the solvents indicated; chemical shifts (δ) are given in ppm relative to TMS, coupling 
constants (J) in Hz. The solvent signals were used as references and the chemical shifts converted to the 




C NMR spectroscopy, respectively; C6D6 at 7.16 




C NMR spectroscopy, respectively; [D5]-pyridine at 8.70, 7.55 and 7.15 
ppm for 
1
H NMR and 149.64, 135.26 and 123.25 ppm for 
13
C NMR spectroscopy, respectively). 
1
H NMR 
data are reported as δ (ppm) (s = singlet, d = doublet, t = triplet, q = quartet, qui = quintet, m = multiplet or 
unresolved, br = broad signal, app = appearing as; coupling constants (J) in Hz; integration). 
13
C NMR 




Sn NMR spectra were recorded using Me4Sn as 
external standard. IR: Spectrum One (Perkin-Elmer) spectrometer, wavenumbers (ṽ) in cm
-1
. MS (EI): 
Finnigan MAT 8200 (70 eV), ESIMS: ESQ 3000 (Bruker), accurate mass determinations: Bruker APEX III 
FT-MS (7 T magnet) or MAT 95 (Finnigan). Unless stated otherwise, all commercially available 
compounds (ABCR, Acros, Aldrich, Strem, Apollo Scientific, TCI) were used as received. [Cp*RuCl2]n was 
prepared according to literature procedures and was stored under Argon.
1
 Ph2PO2NBu4 was prepared 
according to the literature procedures.
2
 Commercial Bu3SnH is stabilized with 0.05% of 3,5-di-tert-butyl-4-




General Procedure for Cadiot-Chodkiewicz Coupling: Preparation of 1-(Octa-1,3-diyn-1-yl)cyclo-
hexan-1-ol (9). CuI (57.0 mg, 0.30 mmol, 5.0 mol%) was added in one portion. at 0°C to a solution of 1-
hexyne (1.4 mL, 12.0 mmol) and 1-(iodoethynyl)cyclohexan-1-ol (1.50 g, 6.00 mmol) in pyrrolidine (12 
mL). The mixture was allowed to warm to room temperature and was stirred for 12 h. A sat. aqueous 
solution of NH4Cl (30 mL) was added and the aqueous phase was extracted with Et2O (3 × 30 mL). The 
combined organic phases were dried over MgSO4, filtered and concentrated in vacuo. The residue was 
purified by flash chromatography (hexane/EtOAc: 98/2 to 96/4) to afford the title compound as a colorless 
S8 
 
oil (1.20 g, 97%). 
 1
H NMR (400 MHz, CDCl3): δ 2.29 (t, J = 6.9 Hz, 2H), 1.99-1.80 (m, 3H), 1.68 (dt, J = 
11.6, 4.3 Hz, 2H), 1.62-1.48 (m, 7H), 1.47-1.36 (m, 2H), 1.32-1.17 (m, 1H), 0.91 (t, J = 7.2 Hz, 3H); 
13
C 
NMR (101 MHz, CDCl3): δ 81.8, 79.2, 69.4, 69.3, 64.6, 39.9, 30.4, 25.2, 23.3, 22.1, 19.1, 13.7; IR (neat, 
cm
-1
): 3341, 2933, 2859, 2249, 1448, 1342, 1290, 1259, 1065, 964; HRMS (ESI): m/z calcd for C14H20ONa 
[M+Na]
+
 227.1406; found: 227.1407. 
 
1-(5-Methylhexa-1,3-diyn-1-yl)cyclohexan-1-ol (1): Prepared analogously as a pale yellow oil (0.74 g, 
48%). 
1
H NMR (400 MHz, CDCl3) δ 2.63 (hept, J = 6.9 Hz, 1H), 2.04 (s, 1H), 1.94-1.84 (m, 2H), 1.73-1.63 
(m, 2H), 1.59-1.47 (m, 5H), 1.29-1.21 (m, 1H), 1.19 (s, 3H), 1.17 (s, 3H); 
13
C NMR (101 MHz, CDCl3) δ 
86.6, 80.0, 69.3, 69.2, 63.9, 39.9, 25.2, 23.3, 22.5, 22.5, 21.2; IR (neat, cm
-1
): 3355, 2971, 2933, 2859, 
2249, 1447, 1384, 1343, 1319, 1288, 1259, 1162, 1064, 963, 903, 848; HRMS (ESI): m/z calcd for 
C13H18ONa [M+Na]
+
 213.1250; found: 213.1248. 
 
2-Methylundeca-4,6-diyn-3-ol (S1): Prepared analogously as a pale yellow oil (0.76 g, 55%). 
1
H NMR 
(400 MHz, CDCl3): δ 4.21 (t, J = 5.8 Hz, 1H), 2.29 (td, J = 7.0, 1.0 Hz, 2H), 1.95-1.83 (m, 1H), 1.79-1.70 
(m, 1H), 1.59-1.47 (m, 2H), 1.47- 1.34 (m, 2H), 1.01 (d, J = 7.6 Hz, 3H), 0.99 (d, J = 7.7 Hz, 3H), 0.91 (t, J 
= 7.2 Hz, 3H); 
13
C NMR (101 MHz, CDCl3): δ 81.6, 75.5, 70.8, 68.5, 64.5, 34.8, 30.3, 22.1, 19.1, 18.2, 
17.6, 13.7; IR (neat, cm
-1
): 3337, 2961, 2933, 2873, 2253, 1466, 1382, 1322, 1028; HRMS (ESI): m/z 
calcd for C12H18ONa [M+Na]
+
 201.1250; found: 201.1250. 
 
2,8-Dimethylnona-4,6-diyn-3-ol (6): Prepared analogously as a pale yellow oil (0.81 g, 55%). 
1
H NMR 
(400 MHz, CDCl3): δ 4.21 (td, J = 5.8, 0.9 Hz, 1H), 2.64 (heptd, J = 6.9, 0.9 Hz, 1H), 1.89 (heptd, J = 6.8, 
5.7 Hz, 1H), 1.74 (d, J = 5.8 Hz, 1H), 1.19 (d, J = 7.0 Hz, 6H), 1.01 (d, J = 6.7 Hz, 3H), 0.99 (d, J = 6.7 Hz, 
3H); 
13





): 3356, 2970, 2932, 2873, 2251, 1467, 1384, 1367, 1318, 1153, 1087, 1025, 951; HRMS (ESI): m/z 
calcd for C11H16ONa [M+Na]
+
 187.1093; found: 187.1090. 
 
Nona-2,4-diyn-1-ol (S2): Prepared analogously as a pale yellow oil (0.29 g, 59%).
 1
H NMR (400 MHz, 
CDCl3): δ 4.32 (dt, J = 6.3, 1.1 Hz, 2H), 2.29 (tt, J = 7.1, 1.1 Hz, 2H), 1.57 (s, 1H), 1.56-1.48 (m, 2H), 1.47-
1.36 (m, 2H), 0.91 (t, J = 7.2 Hz, 3H); 
13
C NMR (101 MHz, CDCl3): δ 82.0, 73.6, 71.1, 64.5, 51.7, 30.3, 
22.0, 19.1, 13.7; IR (neat, cm
-1
): 3332, 2959, 2933, 2872, 2255, 1465, 1426, 1354, 1231, 1022, 633;
 
HRMS (ESI): m/z calcd. for C9H12ONa [M+Na]
+
 159.0780; found: 159.0778. 
 
6-Methylhepta-2,4-diyn-1-ol (S3): Prepared analogously as a pale yellow oil (0.78 g, 82%). 
1
H NMR (400 
MHz, CDCl3): δ 4.32 (d, J = 1.0 Hz, 2H), 2.64 (heptt, J = 7.0, 1.0 Hz, 1H), 1.62 (s, 1H), 1.20 (s, 3H), 1.18 
(s, 3H); 
13
C NMR (101 MHz, CDCl3): δ 86.9, 74.4, 70.9, 63.8, 51.7, 22.5, 21.2; IR (neat, cm
-1
): 3324, 2973, 
2933, 271, 2255, 1467, 1448, 1364, 1320, 1235, 1152, 1087, 1017, 923, 825; HRMS (ESI): m/z calcd for 
C8H10ONa [M+Na]
+
 145.0624; found: 145.0624. 
Ruthenium Catalyzed trans-Hydrostannation Reactions 
 
General Procedure for Hydrostannation at 80°C. Preparation of (Z)-1-(5-Methyl-1-(tributyl-
stannyl)hex-1-en-3-yn-1-yl)cyclohexan-1-ol (2): A solution of tributyltin hydride (42 µL, 0.16 mmol) in 
1,2-dichloroethane (1 mL) was added dropwise (over 60 min) under Argon to a stirred solution of diyne 1 
(27.0 mg, 0.14 mmol) and [Cp*RuCl]4 (1.8 mg, 1.7 µmol, 1.25 mol%) in 1,2-dichloroethane (0.8 mL, 0.2 M) 
at 80°C, which had been mixed at room temperature and stirred for 1-2 min. Once the addition was 
complete, stirring was continued for 5 min at the same temperature before the mixture was allowed to 
reach ambient temperature. The solvent was evaporated and the residue was purified by flash 
chromatography (hexane/CH2Cl2: 80/20 to 70/30) to give the title compound as a light yellow oil (45.0 mg, 
66%). 
1
H NMR (400 MHz, CDCl3): δ 6.31 (d, J = 2.2 Hz, JSn-H = 119.6 Hz, 1H), 2.69 (hept, J = 6.8, 2.1 Hz, 
1H), 1.69-1.61 (m, 1H), 1.58 (m, 4H), 1.54-1.47 (m, 10H), 1.39-1.26 (m, 6H), 1.23 (s, 1H), 1.19 (d, J = 6.9 
Hz, 6H), 1.14-1.09 (m, 1H), 1.08-1.02 (m, 6H), 0.90 (t, J = 7.3 Hz, 9H); 
13
C NMR (101 MHz, CDCl3): δ 
169.0, 116.2, 97.9, 80.1, 76.0, 37.4, 29.4, 27.6, 25.6, 23.0, 22.1, 21.5, 13.9, 12.0; 
119
Sn NMR (149 MHz, 
S10 
 
CDCl3): δ -47.9; IR (neat, cm
-1
): 3412, 2955, 2928, 2854, 2189, 1463, 1376, 1317, 1255, 1161, 1071, 959, 
862, 670; HRMS (ESI): m/z calcd for C25H46OSnNa [M+Na]
+
 505.2462; found: 505.2464. 
 
(Z)-1-(1-(Tributylstannyl)oct-1-en-3-yn-1-yl)cyclohexan-1-ol (S4): Prepared analogously as a pale 
yellow oil (42%, NMR). 
1
H NMR (600 MHz, CDCl3): δ 6.29 (t, J = 2.3 Hz, JSn-H = 118.9 Hz, 1H), 2.31 (td, J 
= 7.2, 2.2 Hz, 2H), 1.70-1.63 (m, 1H), 1.63-1.56 (m, 4H), 1.55-1.44 (m, 12H), 1.44-1.37 (m, 2H), 1.33 (h, J 
= 7.3 Hz, 6H), 1.24 (s, 1H), 1.20-1.11 (m, 1H), 1.06-1.00 (m, 6H), 0.91 (t, J = 7.3 Hz, 3H), 0.89 (t, J = 7.3 
Hz, 9H); 
13
C NMR (151 MHz, CDCl3): δ 169.2, 116.2, 92.7, 80.8, 76.0, 37.5, 30.9, 29.4, 27.6, 25.6, 22.3, 
22.3, 22.1, 19.6, 13.9, 13.8, 12.0; 
119
Sn NMR (149 MHz, CDCl3): δ -48.5; IR (neat, cm
-1
): 3412, 2955, 
2928, 2854, 2183, 1571, 1462, 1376, 1257, 1163, 1071, 958, 863, 668, 595; HRMS (ESI): m/z calcd for 
C26H48OSnNa [M+Na]
+
 519.2619; found: 519.2616. 
 
(Z)-2,8-Dimethyl-4-(tributylstannyl)non-4-en-6-yn-3-ol (7): Prepared analogously as a pale yellow oil 
(67.0 mg, 89%). 
1
H NMR (400 MHz, CDCl3): δ 6.19 (dd, J = 2.1, 1.2 Hz, JSn-H = 111.5 Hz, 1H), 3.81 (ddd, 
J = 7.3, 3.3, 1.2 Hz, JSn-H = 51.1 Hz, 1H), 2.69 (heptd, J = 6.9, 2.0 Hz, 1H), 1.66-1.57 (m, 1H), 1.56-1.47 
(m, 6H), 1.41 (d, J = 3.3 Hz, 1H), 1.39-1.27 (m, 6H), 1.19 (d, J = 6.9 Hz, 6H), 1.09-1.00 (m, 6H), 0.94 (d, J 
= 6.9 Hz, 3H), 0.90 (t, J = 7.3 Hz, 9H), 0.83 (d, J = 6.8 Hz, 3H); 
13
C NMR (101 MHz, CDCl3) : δ 163.1, 
120.1, 97.1, 85.1, 79.9, 33.3, 29.4, 27.6, 23.0, 23.0, 21.4, 20.0, 17.7, 13.9, 10.9; 
119
Sn NMR (149 MHz, 
CDCl3): δ -50.1; IR (neat, cm
-1
): 3479, 2956, 2922, 2871, 220, 1574, 1464, 1376, 1317, 1262, 1135, 1070, 
1014, 595, 870, 667, 596; HRMS (ESI): m/z calcd for C23H44OSnNa [M+Na]
+
 479.2306; found: 479.2303. 
 
(Z)-2-Methyl-4-(tributylstannyl)undec-4-en-6-yn-3-ol (S5): Prepared analogously as a pale yellow oil 
(45.0 mg, 64%). 
1
H NMR (400 MHz, CDCl3): δ 6.18 (q, J = 2.2 Hz, JSn-H = 112.0 Hz, 1H), 3.81 (ddd, J = 
7.3, 3.4, 1.2 Hz, JSn-H = 51.1 Hz, 1H), 2.31 (td, J = 7.1, 2.2 Hz, 2H), 1.65-1.57 (m, 1H), 1.55-1.47 (m, 8H), 
1.44-1.41 (m, 3H), 1.37-1.26 (m, 6H), 1.06-1.00 (m, 6H), 0.94 (d, J = 6.6 Hz, 3H), 0.92-0.87 (m, 12H), 0.83 
(d, J = 6.8 Hz, 3H); 
13
C NMR (101 MHz, CDCl3): δ 163.3, 120.1, 92.0, 85.1, 80.7, 33.3, 30.9, 29.4, 27.6, 
22.3, 20.0, 19.5, 17.7, 13.9, 13.8, 10.9; 
119





2956, 2928, 2871, 2204, 1573, 1463, 1377, 1262, 1073, 1017, 872, 665; HRMS (ESI): m/z calcd for 
C24H46OSnNa [M+Na]
+
: 493.2462; found: 493.2462. 
 
(Z)-6-Methyl-2-(tributylstannyl)hept-2-en-4-yn-1-ol (S6): Prepared analogously as a pale yellow oil 
(64.0 mg, 76%). 
1
H NMR (400 MHz, CDCl3): δ 6.30 (q, J = 1.9 Hz, JSn-H = 109.8 Hz, 1H), 4.27 (dd, J = 6.1, 
1.8 Hz, JSn-H = 30.5 Hz, 2H), 2.68 (heptd, J = 6.9, 2.0 Hz, 1H), 1.60-1.46 (m, 6H), 1.38-1.26 (m, 7H), 1.19 
(d, J = 6.9 Hz, 6H), 1.07-1.01 (m, 6H), 0.90 (t, J = 7.3 Hz, 9H); 
13
C NMR (101 MHz, CDCl3): δ 158.8, 
119.3, 96.9, 80.1, 69.6, 29.4, 27.6, 23.0, 21.4, 13.9, 10.1; 
119
Sn NMR (149 MHz, CDCl3): δ -49.2; IR (neat, 
cm
-1
): 3282, 2956, 2921, 2871, 2852, 2221, 1583, 1463, 1376, 1318, 1071, 1003, 961, 861, 665, 596; 
HRMS (ESI): m/z calcd for C20H38OSnNa [M+Na]
+
 437.1836; found: 437.1837. 
 
(Z)-2-(Tributylstannyl)non-2-en-4-yn-1-ol (S7): Prepared analogously as a pale yellow oil (50.0 mg, 
64%). 
1
H NMR (400 MHz, CDCl3): δ 6.29 (p, J = 2.0 Hz, JSn-H = 109.1 Hz, 1H), 4.27 (dd, J = 6.1, 1.8 Hz, 
JSn-H = 29.3 Hz, 2H), 2.31 (td, J = 7.1, 2.2 Hz, 2H), 1.57-1.47 (m, 8H), 1.47-1.37 (m, 2H), 1.37-1.25 (m, 
7H), 1.13-0.94 (m, 6H), 0.91 (dt, J = 8.7, 7.3 Hz, 12H); 
13
C NMR (101 MHz, CDCl3): δ 159.0, 119.3, 91.7, 
80.8, 69.6, 30.9, 29.4, 27.6, 22.3, 19.5, 13.9, 13.8, 10.1; 
119
Sn NMR (149 MHz, CDCl3): δ -49.6 ; IR (neat, 
cm
-1
): 3309, 2955, 2925, 2871, 2854, 2215, 1577, 1463, 1376, 1291, 1075, 1009, 961, 861, 691, 666, 596;
 
HRMS (ESI): m/z calcd for C21H40OSnNa [M+Na]
+
 451.1993; found: 451.1991. 
 
Representative Procedure for One-pot Hydrostannylation/Proto-destannylation: Preparation of (E)-
1-(5-Methylhex-1-en-3-yn-1-yl)cyclohexan-1-ol (S8): A solution of tributyltin hydride (61 µL, 0.22 mmol) 
in 1,2-dichloroethane (1 mL) was added dropwise (over 30 min) under Argon to a stirred solution of diyne 
1 (25.0 mg, 0.2 mmol) and [Cp*RuCl]4 (2.7 mg, 2.5 µmol, 1.25 mol%) in 1,2-dichloroethane (1 mL, 0.2 M) 
at 80°C, which had been mixed at room temperature and stirred for 1-2 min. Once the addition was 
complete, stirring was continued for 5 min at the same temperature before the reaction mixture was 
allowed to cool to ambient temperature. A solution of Ph2PO2Cu (86.0 mg, 0.3 mmol) in DMF (1 mL) was 
added and the resulting mixture stirred for 20 min. Et2O (5 mL) was added before the reaction was 
quenched with water (5 mL). The aqueous layer was extracted with Et2O (3 × 10 mL) and the combined 
extracts were dried over MgSO4, filtered through a pad of SiO2, and concentrated in vacuo. The crude 
S12 
 
product was purified by flash chromatography (hexane/EtOAc: 90/10) to give the enyne as a colorless oil 
(21.0 mg, 86%). 
1
H NMR (400 MHz, CDCl3): δ 6.16 (d, J = 16.0 Hz, 1H), 5.74 (dd, J = 16.0, 2.0 Hz, 1H), 
2.72 (heptd, J = 6.7, 1.8 Hz, 1H), 1.72-1.60 (m, 2H), 1.59-1.46 (m, 7H), 1.38 (br. s, 1H), 1.31-1.21 (m, 1H), 
1.19 (s, 3H), 1.17 (s, 3H); 
13
C NMR (101 MHz, CDCl3): δ 149.1, 107.9, 96.6, 78.0, 71.9, 37.8, 25.5, 23.1, 
22.0, 21.3; IR (neat, cm
-1
): 3377, 2968, 2931, 2860, 2215, 1630, 1448, 1382, 1319, 1265, 1177, 1133, 
1056, 988, 958; HRMS (ESI): m/z calcd for C13H20ONa [M+Na]
+
 215.1406; found: 215.1405. 
 
(E)-2,8-Dimethylnon-4-en-6-yn-3-ol (S9): Prepared analogously as a colorless oil (23.0 mg, 76%). 
1
H 
NMR (400 MHz, CDCl3) : δ 6.04 (dd, J = 15.9, 6.7 Hz, 1H), 5.68 (ddd, J = 15.9, 2.0, 1.3 Hz, 1H), 3.87 
(ddd, J = 6.9, 5.9, 1.3 Hz, 1H), 2.67 (heptd, J = 6.8, 2.0 Hz, 1H), 1.74 (heptd, J = 6.9, 5.8 Hz, 1H), 1.47 (s, 
1H), 1.18 (d, J = 6.9 Hz, 6H), 0.93 (d, J = 6.8 Hz, 3H), 0.90 (d, J = 6.8 Hz, 3H); 
13
C NMR (101 MHz, 
CDCl3): δ 142.6, 111.6, 96.6, 77.8, 77.7, 33.9, 23.1, 21.3, 18.3, 18.0; IR (neat, cm
-1
): 3375, 2965, 2933, 
2872, 2216, 1632, 1466, 1383, 1365, 1319, 1139, 1074, 1013, 956; HRMS (ESI): m/z calcd for C11H18ONa 
[M+Na]
+
 189.1250; found: 189.1249. 
 
(E)-2-Methylundec-4-en-6-yn-3-ol (S10): Prepared analogously as a colorless oil (29.0 mg, 82%, 
contains some inseparable impurities). 
1
H NMR (400 MHz, CDCl3): δ 6.04 (dd, J = 15.9, 6.8 Hz, 1H), 5.68 
(dtd, J = 15.9, 2.2, 1.3 Hz, 1H), 3.88 (t, J = 6.2 Hz, 1H), 2.30 (td, J = 6.8, 2.2 Hz, 2H), 1.79-1.69 (m, 1H), 
1.54-1.47 (m, 2H), 1.45-1.38 (m, 2H), 0.95-0.88 (m, 9H); 
13
C NMR (101 MHz, CDCl3): δ 142.6, 111.7, 
91.3, 78.6, 77.7, 33.9, 30.9, 22.1, 19.2, 18.3, 18.0, 13.8; IR (neat, cm
-1
): 3373, 2958, 2931, 2872, 2216, 





(E)-6-Methylhept-2-en-4-yn-1-ol (S11): Prepared analogously as a colorless oil (21.0 mg, 85%). 
1
H NMR 
(400 MHz, CDCl3): δ 6.15 (dt, J = 15.8, 5.5 Hz, 1H), 5.72 (dq, J = 15.8, 1.9 Hz, 1H), 4.17 (dd, J = 5.6, 1.5 
Hz, 2H), 2.66 (heptd, J = 6.8, 1.9 Hz, 1H), 1.53 (br. s, 1H), 1.18 (d, J = 6.9 Hz, 6H); 
13
C NMR (101 MHz, 
CDCl3): δ 140.2, 111.5, 96.9, 77.6, 63.3, 23.1, 21.2; IR (neat, cm
-1
): 3342, 2970, 2932, 2871, 2217, 1465, 
S13 
 






Representative Procedure for the trans-Hydrostannation at Low Temperature. Preparation of 1-
((1Z,3Z)-1,4-Bis(tributylstannyl)octa-1,3-dien-1-yl)cyclohexan-1-ol (S12). A solution of tributyltin 
hydride (0.1 mL, 0.37 mmol) in CH2Cl2 (1 mL) was added under Argon via syringe pump over a period of 
60 min to a stirred solution of diyne 9 (30.0 mg, 0.15 mmol) and [Cp*RuCl]4 (4.0 mg, 3.7 µmol, 2.5 mol%) 
in CH2Cl2 (0.75 mL, 0.2 M), which had previously been mixed at room temperature and stirred for 1-2 min. 
Once the addition was complete, stirring was continued for 5 min before the mixture was warmed to 
ambient temperature. The solvent was evaporated and the residue was purified by flash chromatography 
(hexane/CH2Cl2: 90/10) to give the distannane (63 mg, 53%) as a pale yellow oil. 
1
H NMR (400 MHz, 
CDCl3): δ 6.66 (m, JSn-H = 127.5 Hz, JSn-H = 121.6 Hz, 2H), 2.27 (t, J = 6.6 Hz, JSn-H = 51.3 Hz, 2H), 1.71-
1.55 (m, 7H), 1.53-1.41 (m, 14H), 1.37-1.24 (m, 17H), 1.22-1.10 (m, 1H), 1.00-0.82 (m, 33H); 
13
C NMR 
(101 MHz, CDCl3): δ 159.1, 152.5, 141.0, 137.2, 76.2, 41.0, 38.1, 32.8, 29.4, 27.6, 25.8, 22.5, 22.4, 14.2, 
13.9, 12.8, 10.7;
 119
Sn NMR (149 MHz, CDCl3): δ -51.3, -54.3; IR (neat, cm
-1
): 3490, 2954, 2922, 2853, 
1590, 1462, 1376, 1340, 1072, 959, 873, 665, 594; HRMS (ESI): m/z calcd for C38H76OSn2Na [M+Na]
+
 
811.3831; found: 811.3834. 
 
1-((1Z,3Z)-5-Methyl-1,4-bis(tributylstannyl)hexa-1,3-dien-1-yl)cyclohexan-1-ol (3): Prepared 
analogously as a pale yellow oil (54 mg, 44%, isomer ratio  94:6)). 
1
H NMR (400 MHz, CDCl3): δ 6.71 (m, 
JSn-H = 129.9 Hz, JSn-H = 127.8 Hz, 2H), 2.52 (heptd, J = 6.8, 0.8 Hz, 1H), 1.71-1.55 (m, 7H), 1.53-1.40 (m, 
14H), 1.37-1.27 (m, 13H), 1.21-1.11 (m, 1H), 1.03 (d, J = 6.7 Hz, 6H), 1.01-0.91 (m, 12H), 0.88 (t, J = 7.2 
Hz, 9H), 0.88 (t, J = 7.3 Hz, 9H); 
13
C NMR (101 MHz, CDCl3): δ 159.3, 159.2, 137.3, 137.1, 76.2, 38.1, 
37.8, 29.4, 27.6, 25.8, 23.2, 22.4, 13.9, 13.9, 12.8, 11.2; 
119
Sn NMR (149 MHz, CDCl3): δ -50.8, -53.6; IR 
(neat, cm
-1
): 3400, 2954, 2923, 2870, 2853, 1548, 1462, 1376, 1340, 1292, 1146, 1071, 958, 873, 666, 
594; HRMS (ESI): m/z calcd for C37H73OSn2 [M]
-




(4Z,6Z)-2,8-Dimethyl-4,7-bis(tributylstannyl)nona-4,6-dien-3-ol (8): Prepared analogously as a pale 
yellow oil (59 mg, 52%, isomer ratio  80:20). 
1
H NMR (400 MHz, CDCl3): δ 6.68 (m, JSn-H = 129.3 Hz, 
JSnH = 120.4 Hz, 2H), 3.79 (dd, J = 7.8, 3.0 Hz, JSn-H = 57.9 Hz, 1H), 2.60-2.44 (m, 1H), 1.65-1.57 (m, 
1H), 1.56-1.37 (m, 12H), 1.37 (d, J = 3.0 Hz, 1H), 1.38-1.24 (m, 12H), 1.03 (d, J = 6.8 Hz, 6H), 1.03-0.90 
(m, 15H), 0.88 (t, J = 7.3 Hz, 9H), 0.88 (t, J = 7.3 Hz, 9H), 0.82 (d, J = 6.8 Hz, 3H); 
13
C NMR (101 MHz, 
CDCl3): δ 160.2, 152.1, 141.7, 136.6, 86.4, 37.6, 33.9, 29.4, 29.4, 27.6, 27.6, 23.1, 23.1, 20.1, 18.2, 13.8, 
11.5, 11.2; 
119
Sn NMR (149 MHz, CDCl3): δ -50.1; -52.5; IR (neat, cm
-1
): 3501, 2955, 2923, 2871, 2854, 
1551, 1463, 1376, 1290, 1177, 1070, 1008, 881, 666; HRMS (ESI): m/z calcd for C35H72OSn2Na [M+Na]
+
 
771.3518; found: 771.3525. 
 
(4Z,6Z)-2-Methyl-4,7-bis(tributylstannyl)undeca-4,6-dien-3-ol (S13): Prepared analogously as a pale 
yellow oil (80 mg, 62%, isomer ratio  60:40). 
1
H NMR (400 MHz, CDCl3): δ 6.63 (m, JSn-H = 128.1 Hz, JSn-
H = 118.6 Hz, 2H), 3.78 (dd, J = 7.8, 3.0 Hz, JSn-H = 58.2 Hz, 1H), 2.27 (t, J = 6.9 Hz, JSn-H = 49.4 Hz, 2H), 
1.67-1.57 (m, 1H), 1.54-1.39 (m, 12H), 1.38 (d, J = 3.0 Hz, 1H), 1.36-1.25 (m, 16H), 1.02-0.85 (m, 36H), 
0.81 (d, J = 6.8 Hz, 3H); 
13
C NMR (101 MHz, CDCl3): δ 153.5, 152.0, 141.5, 140.5, 86.3, 41.0, 33.9, 32.6, 
29.4, 29.4, 27.6, 27.6, 22.5, 20.1, 18.2, 14.2, 13.9, 13.8, 11.5, 10.7; 
119
Sn NMR (149 MHz, CDCl3): δ -
50.8, -53.1; IR (neat, cm
-1
): 3493, 2955, 2923, 2871, 2854, 1463, 1376, 1071, 1009, 960, 874, 664; HRMS 
(ESI): m/z calcd for C36H74OSn2Na [M+Na]
+
 785.3674; found: 785.3674. 
 
(2Z,4Z)-6-Methyl-2,5-bis(tributylstannyl)hepta-2,4-dien-1-ol (S14): Prepared analogously as a pale 
yellow oil (90 mg, 67%, isomer ratio  86:14). 
1
H NMR (400 MHz, CDCl3): δ 6.79 (m, JSn-H = 116.9 Hz, 
1H), 6.65 (m, JSn-H = 128.9 Hz, 1H), 4.27 (dd, J = 6.1, 1.5 Hz, JSn-H = 38.7, 2H), 2.53 (heptd, J = 6.8, 1.2 
Hz, 1H), 1.54-1.43 (m, 12H), 1.39-1.24 (m, 12H), 1.11 (t, J = 6.1 Hz, 1H), 1.03 (d, J = 6.0 Hz, 6H), 1.01-
0.92 (m, 12H), 0.88 (t, J = 7.3 Hz, 9H), 0.88 (t, J = 7.3 Hz, 9H); 
13
C NMR (101 MHz, CDCl3): δ 160.9, 
147.9, 141.9, 136.8, 70.8, 37.6, 29.4, 29.3, 27.5, 27.5, 23.1, 13.9, 13.8, 11.2, 10.6; 
119
Sn NMR (149 MHz, 
CDCl3): δ -50.4; IR (neat, cm
-1
): 3451, 2955, 2923, 2870, 2852, 1554, 1462, 1418, 1376, 1290, 1180, 







(2Z,4Z)-2,5-Bis(tributylstannyl)nona-2,4-dien-1-ol (S15): Prepared analogously as a pale yellow oil (40 
mg, 31%, isomer ratio  73:27). 
1
H NMR (400 MHz, CDCl3): δ 6.74 (dt, J = 10.6, 1.5 Hz, JSn-H = 114.3 Hz, 
1H), 6.64-6.53 (m, JSn-H = 122.8 Hz, 1H), 4.27 (dd, J = 6.5, 1.5 Hz, JSn-H = 38.8 Hz, 2H), 2.27 (t, J = 6.4 Hz, 
JSn-H = 48.9 Hz, 2H), 1.54-1.42 (m, 12H), 1.37-1.25 (m, 16H), 1.12 (t, J = 6.1 Hz, 1H), 1.03-0.91 (m, 12H), 
0.91-0.85 (m, 21H); 
13
C NMR (101 MHz, CDCl3): δ 154.1, 147.8, 141.7, 140.7, 70.8, 41.0, 32.6, 29.4, 
29.4, 27.5, 27.5, 22.4, 14.2, 13.9, 13.8, 10.7, 10.6; 
119
Sn NMR (149 MHz, CDCl3): δ -50.8, -50.8; IR (neat, 
cm
-1
): 3468, 2955, 2922, 2871, 2852, 1556, 1463, 1376, 1291, 1072, 1002, 960, 874, 689, 666, 595;
 
HRMS (ESI): m/z calcd for C33H68OSn2Na [M+Na]
+
 743.3205; found: 743.3199. 
 
Representative Procedure for One-pot Di-hydrostannation/Proto-destannation. Preparation of 1-
((1E,3E)-5-Methylhexa-1,3-dien-1-yl)cyclohexan-1-ol (S16): A solution of tributyltin hydride (0.14 mL, 
0.50 mmol) in CH2Cl2 (1 mL) was added dropwise (over 30 min) under Argon at -20°C to a stirred solution 
of diyne 1 (40.0 mg, 0.2 mmol) and [Cp*RuCl]4 (6.7 mg, 6.1 µmol, 3.0 mol%) in CH2Cl2 (1 mL, 0.2 M), 
which had previously been mixed at room temperature and stirred for 1-2 min. Once the addition was 
complete, stirring was continued for 5 min before the mixture was warmed to ambient temperature. A 
solution of Ph2PO2Cu (0.17 g, 0.60 mmol) in DMF (2 mL) was added and stirring continued for 1 h. Et2O (5 
mL) was added and the reaction was quenched with water (5 mL). The aqueous layer was extracted with 
Et2O (3 × 10 mL) and the combined extracts were dried over MgSO4, filtered through a pad of SiO2, and 
concentrated in vacuo. The crude material was purified by flash chromatography (hexane/EtOAc: 90/10) 
to give the title compound as a colorless oil (32.0 mg, 78%).
 1
H NMR (400 MHz, CDCl3): δ 6.23 (ddd, J = 
15.5, 10.3, 0.7 Hz, 1H), 6.00 (m, 1H), 5.71 (d, J = 15.8 Hz, 1H), 5.70 (dd, J = 15.2, 6.7 Hz, 1H), 2.33 (appt. 
octet of doublet, J = 6.7, 1.3 Hz, 1H), 1.70-1.44 (m, 10H), 1.38-1.23 (m, 1H), 1.01 (d, J = 6.7 Hz, 6H); 
13
C 
NMR (101 MHz, CDCl3): δ 142.0, 139.0, 128.0, 127.0, 71.6, 38.2, 31.3, 25.7, 22.4, 22.3; IR (neat, cm
-1
): 
3362, 3023, 2958, 2930, 2862, 1448, 1382, 1263, 1171, 989, 955;
 
HRMS (EI): m/z calcd for C13H22O [M]
+
 
194.1665; found: 194.1668. 
 
(4E,6E)-2-Methylundeca-4,6-dien-3-ol (S17): Prepared analogously as a colorless oil (21.0 mg, 85%). 
1
H 
NMR (400 MHz, CDCl3): δ 6.18 (dd, J = 15.0, 10.5 Hz, 1H), 6.03 (ddt, J = 15.1, 10.7, 1.1 Hz, 1H), 5.69 (dt, 
S16 
 
J = 14.7, 7.0 Hz, 1H), 5.57 (dd, J = 15.2, 7.2 Hz, 1H), 3.85 (ddd, J = 7.1, 5.9, 1.0 Hz, 1H), 2.08 (q, J = 7.6, 
7.0 Hz, 2H), 1.81-1.65 (octet, J = 6.9 Hz, 1H), 1.48 (br. s, 1H), 1.42-1.25 (m, 4H), 0.93 (d, J = 6.8 Hz, 3H), 
0.92-0.86 (m, 6H); 
13
C NMR (101 MHz, CDCl3): δ 135.5, 132.1, 131.9, 129.6, 78.1, 34.1, 32.5, 31.5, 22.4, 
18.4, 18.2, 14.1; IR (neat, cm
-1
): 3373, 3017, 2957, 2926, 2872, 1466, 1379, 1257, 1132, 986; HRMS (EI): 
m/z calcd for C12H22O [M]
+
 182.1665; found: 182.1666. 
 
(2E,4E)-6-Methylhepta-2,4-dien-1-ol (S18): Prepared analogously as a colorless oil (14.0 mg, 56%). 
1
H 
NMR (400 MHz, CDCl3): δ 6.21 (ddt, J = 15.1, 10.3, 1.3 Hz, 1H), 6.01 (ddt, J = 15.7, 10.4, 0.9 Hz, 1H), 
5.80-5.64 (m, 2H), 4.16 (dd, J = 6.7, 1.3 Hz, 2H), 2.34 (appt. octet of doublet, J = 6.7, 1.2 Hz, 1H), 1.31 (s, 
1H), 1.01 (d, J = 6.7 Hz, 6H); 
13
C NMR (101 MHz, CDCl3): δ 142.9, 132.4, 129.7, 126.5, 63.7, 31.2, 22.4; 
IR (neat, cm
-1
): 3321, 3021, 2959, 2927, 2868, 1464, 1382, 1363, 1087, 987; HRMS (EI): m/z calcd for 
C8H14O [M]
+
 126.1039; found: 126.1041. 
 
Typhonosides E and F 
 
Eicosanal (S19): A flame-dried 100 mL round bottom flask was charged with 1-eicosanol (4.00 g, 13.4 
mmol) and CH2Cl2 (200 mL). PCC (3.18 g, 14.8 mmol) was added and the mixture stirred at room 
temperature for 24 h. Celite (5.00 g) was introduced into the brown suspension. The resulting mixture was 
stirred for 30 min before it was filtered through a pad of Celite. The solid was carefully washed with CH2Cl2 
(50 mL) and the combined filtrates were concentrated. The title compound was obtained as a white solid 
by flash chromatography (hexane:EtOAc = 10:1) (3.60 g, 91%)  
1
H NMR (400 MHz, CDCl3): δ 9.76 (t, J = 
1.9 Hz, 1H), 2.41 (td, J = 7.4, 1.9 Hz, 2H), 1.74-1.50 (m, 2H), 1.25 (m, 32H), 0.91-0.79 (m, 3H); 
13
C NMR 
(100 MHz, CDCl3): δ 203.0, 43.9, 31.9, 29.70 (signals unresolved), 29.67, 29.65, 29.6, 29.44, 29.37, 29.2, 
22.7, 22.1, 14.1; IR (neat, cm
-1
): 2961, 2953, 2848, 2747, 1711, 1471, 1410, 1391, 1374, 895, 717; HRMS 
(EI): m/z calcd for C20H40O [M]: 296.3079; found: 296.3078.  
 
Heneicos-1-ene (S20): A 50 mL Schlenk tube was charged with a solution of 
methyl(triphenyl)phosphonium bromide (1.96 g, 5.51 mmol) in THF (20 mL). The solution was cooled to 
78°C and stirred for 15 min before n-BuLi (5.51 mmol, 3.80 mL, 1.45 M in hexane) was added dropwise at 
S17 
 
this temperature. The resulting yellow suspension was stirred at -78°C for 15 min before it was warmed to 
room temperature. After stirring for 15 min, the mixture was cooled again to -78°C. A solution of eicosanal 
(1.48 g, 5.00 mmol) was added dropwise at -78°C, the mixture was warmed to room temperature and 
stirring was continued for 24 h. For work up, the mixture was filtered, the filtrated was concentrated and 





H NMR (400 MHz, CDCl3): δ 5.82 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 4.99 (app dq, 1H), 4.93 (ddt, 
J = 10.2, 2.3, 1.2 Hz, 1H), 2.08-2.00 (m, 2H), 1.42-1.34 (m, 2H), 1.26 (m, 32H), 0.91-0.83 (m, 3H); 
13
C 
NMR (100 MHz, CDCl3): δ 139.3, 114.1, 33.8, 32.0, 29.72 (signals unresolved), 29.69, 29.65, 29.5, 29.4, 
29.2, 29.0, 22.7, 14.1; IR (neat, cm
-1
): 2955, 2852, 1641, 1466, 1378, 1057, 922, 907, 735; HRMS (EI): 
m/z calcd for C21H42 [M]: 294.3287; found: 294.3281.  
 
(R)-Heneicosane-1,2-diol (S21): A suspension of AD-mix-β (2.25 g) in t-BuOH/H2O (36 mL, v:v = 1:1) 
was stirred vigorously for 30 min at room temperature. The resulting mixture was then cooled to 0°C 
before heneicos-1-ene (0.57 g, 1.93 mmol) was added The mixture was vigorously stirred at 0°C for 96 h. 
Sodium sulfite (2.40 g, 19.0 mmol) was then added to the suspension and stirring was continued for 60 
min before the mixture was warmed to room temperature. The suspension was extracted with EtOAc (3 × 
50 mL). The combined organic layers were washed with brine (20 mL), dried over MgSO4, filtered and 
concentrated. The diol product was isolated by flash chromatography (hexane:EtOAc = 1:2 to 
CH2Cl2:MeOH = 20:1) as a white solid (249.9 mg, 39%, 86% ee). Recrystallization from EtOAc (40 mL 




= +1.9 (c = 
2.01, CHCl3:MeOH = 1:1). 
1
H NMR (400 MHz, CDCl3): δ 3.74-3.61 (m, 2H), 3.44 (ddd, J = 12.1, 7.5, 4.7 
Hz, 1H), 1.96 (d, J = 3.9 Hz, 1H), 1.82 (dd, J = 4.7 Hz, 1H), 1.50-1.40 (m, 3H), 1.25 (m, 33H), 0.93-0.80 
(m, 3H). 
13
C NMR (100 MHz, CDCl3): δ 72.3, 66.9, 33.2, 31.9, 29.71 (signals unresolved), 29.68, 29.67, 
29.60, 29.56, 29.4, 25.5, 22.7, 14.1; IR (neat, cm
-1
): 3477, 3309, 3225, 2954, 2915, 2847, 1470, 1073, 
873, 719; HRMS (ESI): m/z calcd for C21H44O2Na [M+Na]
+
: 351.3233; found: 351.3235. 
The absolute configuration was assigned as (R) in analogy to a similar compound described by Bittman 
and co-workers.
4
 The enantiomeric excess was determined by Mosher ester derivatization. To this end, a 
flamed-dried 5 mL round bottom flask was charged with the diol (1.6 mg, 0.005 mmol) and DMAP (0.6 mg, 
0.005 mmol) in CH2Cl2 (0.1 mL). Triethylamine (5.1 mg, 0.152 mmol) was then added, followed by the 
addition of (S)-(+)-MTPA-Cl (3.8 mg, 0.015 mmol). The mixture was allowed to stir at room temperature 
for 6 h. The solvent was evaporated and the residue subjected to 
1
H NMR analysis. The enantiomeric 
excess of the diol was determined to be >95% based on the -OMe signals; for comparison, the racemic 







(R)-1-((tert-Butyldimethylsilyl)oxy)heneicosan-2-yl acetate (S22): To a suspension of the (R)-
heneicosane-1,2-diol (149.8 mg, 0.46 mmol) in CH2Cl2 (7 mL) was added pyridine (361.9 mg, 4.57 mmol) 
followed by TBSCl (89.3 mg, 0.59 mmol) at 0°C. The mixture was allowed to stir at room temperature for 
54 h. The suspension turned into a clear solution at this point. The mixture was cooled to 0°C before 
acetic anhydride (248.4 mg, 2.43 mmol) was introduced and stirring was continued for 24 h. MeOH (0.1 
mL) was added, the solution was diluted with water (5 mL) and CH2Cl2 (5 mL). The aqueous layer was 
extracted with CH2Cl2 (3 × 10 mL), the combined organic layers were washed with brine (10 mL), dried 
over MgSO4, filtered and concentrated. The product was isolated by flash chromatography (EtOAc:hexane 




= -66.7 (c = 0.50, CHCl3). 
1
H NMR (400 
MHz, CDCl3): δ 4.88 (dddd, J = 7.7, 5.2, 5.2, 5.2 Hz, 1H), 3.62 (d, J = 5.1 Hz, 2H), 2.05 (s, 3H), 1.25 (m, 
36H), 0.88 (s, 9H), 0.88 (m, 3H), 0.04 (s, 6H); 
13
C NMR (100 MHz, CDCl3): δ 170.8, 74.7, 64.3, 31.9, 30.5, 
29.71 (signals unresolved), 29.68, 29.67, 29.6, 29.54, 29.50, 29.4, 25.8, 25.2, 22.7, 21.3, 18.3, 14.1, -5.4; 
IR (neat, cm
-1
): 2924, 2854, 1744, 1464, 1370, 1238, 1122, 837, 777; HRMS (ESI): m/z calcd for 
C29H60O3SiNa [M+Na]
+





(R)-1-Hydroxyheneicosan-2-yl acetate (S23): aq. HCl (1 M, 0.47 mL, 0.47 mmol) was added to a 
solution of (R)-1-((tert-butyldimethylsilyl)oxy) heneicosan-2-yl acetate (206.0 mg, 0.42 mmol) in THF (4 
mL). The solution was stirred at room temperature for 5 h before NaHCO3 (42 mg, 0.50 mmol) was 
carefully added. The mixture was diluted with EtOAc (5 mL) and H2O (5 mL) and the aqueous layer was 
extracted with EtOAc (3 × 10 mL). The combined organic phases were washed with brine (10 mL), dried 
over MgSO4, filtered and concentrated. The residue was subjected to flash chromatography 
(hexane:EtOAc = 1:4) to give the title compound as a viscous liquid (126.0 mg, 80%). [𝜶]𝟐𝟎
𝑫  
= -1.1 (c = 
0.55, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ 4.91 (ddt, J = 9.5, 6.3, 3.2 Hz, 1H), 3.72 (dd, J = 12.0, 3.1 Hz, 
1H), 3.63 (dd, J = 12.0, 6.3 Hz, 1H), 2.09 (s, 3H), 1.84 (s, 1H), 1.62-1.49 (m, 2H), 1.25 (s, 34H), 0.94-0.72 
(m, 3H); 
13
C NMR (100 MHz, CDCl3): δ 171.5, 75.7, 64.9, 31.9, 30.5, 29.71 (signals unresolved), 29.67, 
29.64, 29.56, 29.5, 29.4, 25.3, 22.7, 21.2, 14.1; IR (neat, cm
-1
): 3416, 2916, 2849, 1737, 1467, 1374, 
1238, 1051, 1028, 721, 610; HRMS (ESI): m/z calcd for C23H46O3Na [M+Na]
+
: 393.3339; found: 393.3340.  
 
(R)-2-Acetoxyheneicosanoic acid (S24): RuCl3 hydrate (2.3 mg, 0.011 mmol) was added to a vigorously 
stirred mixture of (R)-1-hydroxyhenicosan-2-yl acetate (101.2 mg, 0.27 mmol) and NaIO4 (175.2 mg, 0.82 
mmol) in CH2Cl2/MeCN/H2O (1:1:1.5, v/v). Stirring was continued at room temperature for 2 h before the 
mixture was diluted with water (5 mL) and EtOAc (15 mL). The aqueous layer was extracted with EtOAc (3 
× 15 mL), the combined organic phases were washed with brine and dried over MgSO4, filtered and 
concentrated. The residue was subjected to flash chromatography (hexane:EtOAc = 2:1 to 




= +11.5 (c = 0.50, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ 5.02 (dd, J = 6.3, 6.3 Hz, 1H), 2.15 (s, 3H), 1.91-
1.81 (m, 2H), 1.47-1.37 (m, 2H), 1.26 (m, 32H), 0.88 (t, J = 6.9 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ 
176.2, 170.7, 72.0, 31.9, 31.0, 29.71 (signals unresolved), 29.67, 29.63, 29.55, 29.37, 29.36, 29.1, 25.1, 
22.7, 20.6, 14.1; IR (neat, cm
-1
): 2916, 2849, 1734, 1725, 1468, 1374, 1229, 1086, 1049, 907, 649; HRMS 
(ESI): m/z calcd for C23H44O4Na [M+Na]
+
: 407.3132; found: 407.3133. 
 
2-(Pent-4-yn-1-yloxy)tetrahydro-2H-pyran (S25): 3,4-Dihydro-2H-pyrane (75.0 mmol, 6.84 mL) and 
TsOH·H2O (95.1 mg, 0.50 mmol) were added to a solution of 4-pentyn-1-ol (50.0 mmol, 6.84 mL) in 
CH2Cl2 (100 mL) at 0°C under Ar. After stirring for 18 h at room temperature, the resulting dark brown 
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mixture was diluted with sat. aq. NaHCO3. The water layer was extracted with EtOAc, the combined 
organic phases were dried over Na2SO4, filtrated, and concentrated. The crude product was purified by 
flash chromatography (hexane:EtOAc = 98:2) to afford the title compound as a colorless liquid (7.83 g, 
93%). 
1
H NMR (400 MHz, CDCl3): δ 4.60 (t, J = 2.7 Hz, 1H), 3.90-3.80 (m, 2H), 3.55-3.44 (m, 2H), 2.32 
(tdd, J = 7.0, 2.7, 0.9 Hz, 2H), 1.94 (t, J = 5.2 Hz, 1H), 1.88-1.78 (m, 3H), 1.76-1.67 (m, 1H), 1.62-1.48 (m, 
4H); 
13
C NMR (100 MHz, CDCl3): δ 98.8, 84.0, 68.4, 65.8, 62.2, 30.7, 28.7, 25.5, 19.5, 15.3; IR (neat, cm
-
1
): 3295, 2941, 2871, 1441, 1354, 1323, 1261, 1200, 1158, 1136, 1120, 1061, 1033, 1020, 992, 868, 627; 
HRMS (ESI): m/z calcd for C10H16O2Na [M+Na]
+
: 191.1048; found: 191.1042.  
 
Tetradec-4-yn-1-ol (15): n-BuLi (1.6 M in hexane, 30.9 mL, 49.5 mmol) was added dropwise to the 
solution of 2-(tetradec-4-yn-1-yloxy)tetrahydro-2H-pyran (7.57 g, 45.0 mmol) in THF (130 mL) at -78°C 
under Ar and the resulting pale yellow solution was stirred at -78°C for 1 h. After warming to room 
temperature, 1-iodononane (10.7 mL, 54.0 mmol) was introduced, and the resulting mixture was stirred at 
reflux temperature for 20 h.  The reaction was quenched with sat. aq. NH4Cl at 0°C. The water layer was 
extracted with EtOAc, and the combined organic phases were dried over Na2SO4, filtrated, and 
evaporated under reduced pressure.  
TsOH·H2O (171.0 mg, 0.90 mmol) was added to a solution of the pale yellow residue in MeOH (100 mL) 
under Ar. The mixture was stirred for 21 h at room temperature before NEt3 (0.5 mL) and water were 
added. The aqueous layer was extracted with EtOAc and the combined organic phases were dried over 
Na2SO4 and concentrated. The crude material was purified by flash chromatography (hexane:EtOAc = 




H NMR (400 MHz, CDCl3): δ 3.76 (t, 
J = 6.1 Hz, 2H), 2.28 (tt, J = 6.8, 2.4 Hz, 2H), 2.13 (tt, J = 7.0, 2.4 Hz, 2H), 1.74 (app qui, J = 6.2 Hz, 2H), 
1.47 (app qui, J = 7.5 Hz, 2H), 1.40-1.22 (m, 12H), 0.88 (t, J = 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ 
81.2, 79.2, 62.1, 31.9, 31.6, 29.5, 29.3, 29.2, 29.1, 28.9, 22.7, 18.7, 15.5, 14.1; IR (neat, cm
-1
): 3332, 
2924, 2854, 1466, 1434, 1378, 1331, 1056, 908, 733, 648; HRMS (ESI): m/z calcd for C14H26ONa 
[M+Na]
+





Tetradec-4-ynal (S26): A solution of DMSO (5.3 mL, 75.0 mmol) in CH2Cl2 (20 mL) was added dropwise 
over 20 min to the solution of oxalyl chloride (3.2 mL, 37.5 mmol) in CH2Cl2 (40 mL) at -78°C under Ar. 
The resulting mixture was stirred for 15 min before a solution of tetradec-4-yn-1-ol (5.26 g, 25.0 mmol) in 
CH2Cl2 (20 mL) was added dropwise over 20 min at -78°C. After vigorous stirring for 20 min, NEt3 (20.9 
mL, 150.0 mmol) was introduced and the resulting mixture was vigorously stirred for 30 min at -78°C and 
for another 30 min at 0°C. The white suspension was diluted with sat. NH4Cl aq. After separation of the 
organic phase, the water layer was extracted with CH2Cl2, and the combined organic phases were washed 
twice with brine, dried over Na2SO4, and evaporated. The residue was purified by flash chromatography 
(hexane:EtOAc = 100:0 to 97:3) to give the product as a colorless liquid (3.59 g, 69%). 
1
H NMR (400 MHz, 
CDCl3): δ 9.80 (t, J = 1.4 Hz, 1H), 2.61 (tt, J = 7.0, 1.3 Hz, 2H), 2.48 (tt, J = 7.0, 2.4 Hz, 2H), 2.12 (tt, J = 
7.2, 2.4 Hz, 2H), 1.46 (app qui, J = 7.7 Hz, 2H), 1.38-1.22 (m, 12H), 0.88 (t, J = 7.0 Hz, 3H); 
13
C NMR 
(100 MHz, CDCl3): δ 201.1, 81.7, 77.7, 43.0, 31.9, 29.5, 29.3, 29.2, 28.93, 28.86, 22.7, 18.7, 14.1, 12.2; 
IR (neat, cm
-1
): 2923, 2854, 2726, 1728, 1466, 1436, 1411, 1378, 1357, 1333, 1113, 1054, 722; HRMS 
(ESI): m/z calcd for C14H24ONa [M+Na]
+
: 231.1725; found: 231.1719. 
 
 
Pentadeca-1,5-diyne (16): PPh3 (15.7 g, 60.0 mmol) was added to a solution of CBr4 (9.95 g, 30.0 mmol) 
in CH2Cl2 (75 mL) under Ar at 0°C. A solution of tetradec-4-ynal (3.13 g, 15.0 mmol) in CH2Cl2 (25 mL) 
was added dropwise to the resulting orange mixture at 0°C and stirring was continued for 3 h at room 
temperature. The dark brown mixture was filtered through the pad of silica, eluting with EtOAc. The 
combined filtrates were evaporated. The residue was repeatedly triturated with hexane, and the combined 
hexane extracts were evaporated under reduced pressure.  
n-BuLi (1.6 M in hexane, 23.4 mL, 37.5 mmol) was added under Ar atmosphere to the solution of the 
residue in THF (80 mL) at -78°C. After stirring for 1 h at -78°C, the reaction was quenched at this 
temperature with sat. aq. NH4Cl. The water layer was extracted with ether, the combined organic phases 
were dried over Na2SO4, filtrated, and evaporated. The residue was purified by flash chromatography 
(hexane) to afford pentadeca-1,5-diyne as a pale yellow liquid (2.60 g, 85%). 
1
H NMR (400 MHz, CDCl3): 
δ 2.42-2.38 (m, 4H), 2.15 (tt, J = 7.0, 2.0 Hz, 2H), 2.00 (t, J = 2.5 Hz, 1H), 1.48 (app qui, J = 7.2 Hz, 2H), 
1.41-1.24 (m, 12H), 0.88 (t, J = 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ 83.1, 81.6, 78.1, 69.0, 31.9, 
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29.5, 29.3, 29.2, 29.0, 28.8, 22.7, 19.2, 18.9, 18.7, 14.1; IR (neat, cm
-1
): 3314, 2923, 2854, 1466, 1338, 
1257, 722, 632; HRMS (ESI): m/z calcd for C15H24Na [M+Na]
+
: 227.1776; found: 227.1770. 
 
 
tert-Butyl (S)-4-((R)-1-hydroxyhexadeca-2,6-diyn-1-yl)-2,2-dimethyloxazolidine-3-carboxylate (17): 
n-BuLi (1.6 M in hexane, 2.6 mL, 3.78 mmol) was added to a solution of pentadeca-1,5-diyne (866.0 mg, 
4.24 mmol) in THF (40 mL) under Ar at -20°C and stirring continued at this temperature for 2 h. Freshly 
distilled DMPU (835.6 mg, 6.52 mmol)
8
 was added, followed by a solution of the Garner’s aldehyde (747.4 
mg, 3.26 mmol) in THF (15 mL) over a period of 15 min at -78°C. The mixture was allowed to stir at this 
temperature for 1 h and for another 2 h at -20°C before the reaction was quenched with water and sat. 
NH4Cl solution (25 mL). After reaching ambient temperature, the mixture was extracted with EtOAc (3 × 
25 mL). The combined organic layers were dried over MgSO4, filtered and concentrated. The crude 
product was purified by flash chromatography (EtOAc:hexane = 10:1 to 8:1) to afford the title compound 
as a colorless liquid (1.09 g, 77% yield of the anti-isomer).
9
 The diastereoselectivity (anti:syn > 20:1) was 
determined by recording the spectrum of the crude material in [D6]-DMSO and comparison of the data with 




= -42.5 (c = 0.42, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ 
4.75-4.66 (m, 2H), 4.36-3.85 (m, 3H), 2.43-2.32 (m, 4H), 2.16-2.10 (tt, J = 7.0, 2.1 Hz, 2H), 1.59 (s, 3H), 
1.52-1.43 (m, 14H), 1.38-1.23 (m, 12H), 0.88 (t, J = 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ 154.2, 
95.0, 85.1, 81.5, 81.3, 78.8, 78.2, 65.1, 64.1, 62.8, 31.9, 29.5, 29.3, 29.2, 29.0, 28.9, 28.4, 25.8, 25.5, 
22.7, 19.5, 19.0, 18.7, 14.1; IR (neat, cm
-1
): 3444, 2925, 2855, 1692, 1457, 1389, 1257, 1207, 1170, 1082, 
1065, 847, 769; HRMS (ESI): m/z calcd for C26H43O4Na [M+Na]
+
: 456.3090; found: 456.3084. 
 
tert-Butyl-(S)-4-((S,2Z,6Z)-1-hydroxy-2,6-bis(tributylstannyl)hexadeca-2,6-dien-1-yl)-2,2-dimethyl-
oxazolidine-3-carboxylate (18): [Cp*RuCl]4 (2.7 mg, 0.0025 mmol) was added to a solution of the diyne 
(21.7 mg, 0.05 mmol) in CH2Cl2 (1.0 mL) under Ar, causing an immediate color change from brown to 
slight purple. The mixture was stirred at -20°C for 5 min before a solution of n-Bu3SnH (36.4 mg, 0.13 
mmol) in 1,2-dichloroethane (0.5 mL) was added via syringe pump over a period of 2 h. Once the addition 
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was complete, stirring was continued for an extra 5 min. After removal of the solvent, the resulting crude 
material was subjected to flash chromatography (hexane:EtOAc = 98:2) to give the distannane product as 






H NMR analysis of the crude reaction mixture in CDCl3, the E/Z diastereoselectivity of the 
diene was determined to be Z/Z:Z/E > 20:1. The regioisomeric ratio of the major Z/Z alkene product was 
determined to be 55:45; these regioiosmers were not separated.  
 
Compound characterization was performed using C6D6 due to gradual decomposition of the distannane in 
chlorinated solvents. [𝜶]𝟐𝟎
𝑫  
= -2.7 (c = 0.41, CHCl3). 
1
H NMR (400 MHz, C6D6): δ 6.34 (t, J = 6.5 Hz, JSn-H = 
132.8 Hz, 2H), 4.31 (br s, 1H), 4.14 (m, 2H), 3.80-3.57 (m, 1H), 2.57-2.13 (m, 6H), 1.77 (m, 6H), 1.71-1.63 
(m, 9H), 1.56-1.26 (m, 44H), 1.16-1.10 (m, 6H), 1.06-0.96 (m, 18H), 0.93-0.89 (m, 3H); 
13
C NMR (100 
MHz, C6D6): δ 152.3, 147.0, 146.6, 144.37, 142.4, 141.3, 140.0, 139.8, 93.4, 80.4, 79.2, 64.6, 61.0, 41.4, 
41.1, 36.0, 35.6, 35.4, 35.1, 32.0, 31.0, 30.6, 29.84, 29.75, 29.68, 29.65, 29.6, 29.48, 29.46, 28.2, 28.1, 
28.0, 27.9, 27.79, 27.75, 27.6, 27.3, 24.4, 22.8, 14.0, 13.74, 13.70, 13.64, 13.63, 12.0, 11.9, 10.5, 10.4; 
119
Sn NMR (186 MHz, C6D6): δ -53.6,. -53.9, -58.7 (br s); IR (neat, cm
-1
): 2955, 2922, 2853, 1693, 1457, 
1386, 1375, 1365, 1248, 1202, 1174, 1099, 1072, 1051, 871, 846, 735; HRMS (ESI): m/z calcd for 
C50H99NO4Sn2Na [M+Na]
+






(S27): CuTC (170.3 mg, 0.89 mmol) was added to a solution of distannane 18 (184.2 mg, 0.18 mmol) and 
Ph2PO2NBu4 (370.4 mg, 0.81 mmol) in DMF (2.2 mL) and the resulting mixture was stirred at room 
temperature for 2 h. tert-Butyl methyl ether (10 mL) was added before the reaction was quenched with 
water (10 mL). The resulting yellow mixture was stirred at room temperature for an extra 30 min. The 
aqueous layer was extracted with tert-butyl methyl ether (3 × 30 mL). The combined organic phases were 
dried over MgSO4 and filtered through a pad of SiO2. After evaporation of the solvent, the residue was 





= -22.4 (c = 0.78, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ 5.74 (dt, J = 15.4, 6.2 Hz, 1H), 
5.53-5.33 (m, 3H), 4.40-3.78 (br m, 5H), 2.15-2.03 (m, 4H), 1.96 (app q, J = 5.4 Hz, 2H), 1.60-1.45 (m, 
15H), 1.38-1.22 (m, 14H), 0.88 (t, J = 7.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ 154.2, 132.7, 131.0, 
129.3, 128.5, 94.4, 81.0, 74.0, 64.9, 62.3, 32.59, 32.55, 32.2, 31.9, 29.6, 29.5, 29.3, 29.2, 28.4, 26.3, 24.6, 
22.7, 14.1; IR (neat, cm
-1
): 3437, 2957, 2923, 2853, 1698, 1455, 1385, 1376, 1255, 1173, 1097, 1069, 
965, 848, 766; HRMS (ESI): m/z calcd for C26H47NO4Na [M+Na]
+
: 460.3403; found: 460.3397. 
 
tert-Butyl-(S)-4-((R,2E,6E)-1-(benzoyloxy)hexadeca-2,6-dien-1-yl)-2,2-dimethyloxazolidine-3-
carboxylate (19): DCC (18.1 mg, 0.088 mmol) was added to a solution of the allylic alcohol (19.4 mg, 
0.044 mmol), benzoic acid (10.7 mg, 0.088 mmol) and DMAP (16.2 mg, 0.13 mmol) in CH2Cl2 (2 mL), 
causing the formation of a white precipitate. The mixture was stirred at room temperature for 24 h before 
the reaction was quenched with MeOH (0.1 mL). After stirring for an extra 15 min, the mixture was diluted 
with hexane and insoluble material was filtered off. The solid was washed with hexane/EtOAc (25:1, 10 
mL), the combined filtrates were concentrated and the residue was subjected to flash chromatography 




H NMR (400 
MHz, C6D6, rotamers at room temperature): δ 8.30 (m, 2H), 7.11-7.03 (m, 3H), 6.38 (br s, 0.4H), 6.32 (br 
s, 0.6H), 5.88 (dt, J = 14.4 Hz, 6.4 Hz, 1H), 5.58-5.29 (m, 3H), 4.27 (br s, 0.4H), 4.17 (d, J = 8.9 Hz, 0.6H), 
4.11 (d, J = 8.9 Hz, 0.4H), 3.89 (br s, 0.6H), 3.80-3.62 (m, 1H), 1.99 (m, 6H), 1.70 (s, 2H), 1.55 (m, 8H), 
1.38 (m, 6H), 1.28 (m, 13H), 0.94-0.87 (m, 3H); 
13
C NMR (100 MHz, C6D6, rotamers at room temperature): 
δ 165.2, 165.0, 152.2, 151.5, 134.6, 134.5, 132.6, 132.4, 131.3, 131.0, 130.7, 129.9, 129.2, 129.0, 128.2, 
126.1, 94.7, 93.7, 79.5, 74.1, 73.8, 63.5, 63.4, 60.2, 60.0, 32.7, 32.4, 32.1, 32.0, 29.71, 29.68, 29.6, 29.4, 
29.3, 28.1, 28.0, 27.2, 26.3, 24.3, 22.9, 22.8, 14.0. IR (neat, cm
-1
): 2974, 2925, 2854, 1725, 1703, 1425, 
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1376, 1269, 1176, 1098, 711; HRMS (ESI): m/z calcd for C33H51NO5Na [M+Na]
+
: 564.3659; found: 
564.3665; [𝛼]20
𝐷  
= -33.2 (c = 0.51, CHCl3). 
 
2,5-Dioxopyrrolidin-1-yl (R)-2-acetoxyheneicosanoate. DCC (5.3 mg, 0.026 mmol) was added to a 
solution of (R)-2-acetoxyhenicosanoic acid (9.1 mg, 0.024 mmol) and N-hydroxysuccinimide (3.2 mg, 
0.027 mmol) in THF (0.15 mL) at 0°C. The mixture was stirred at 0°C for 1 h and at room temperature 
overnight. Water (1.5 mg, 0.08 mmol) was added and stirring continued for 1 h. Hexane (1 mL) was 
introducded, the precipitated dicyclohexylurea was filtered off and rinsed with hexane/EtOAc (10:1, 10 
mL). The combined filtrates were dried over MgSO4 and concentrated. The resulting crude 2,5-
dioxopyrrolidin-1-yl (R)-2-acetoxyheneicosanoate (23) was used directly in the next step without further 
purification.  
 
(2S,3R,4E,8E)-2-((R)-2-Acetoxyhenicosanamido)-1-hydroxyoctadeca-4,8-dien-3-yl benzoate (20). aq 
HCl (2 M, 0.05 mL) was added to a stirred solution of tert-butyl-(S)-4-((R,2E,6E)-1-(benzoyloxy)hexadeca-
2,6-dien-1-yl)-2,2-dimethyl oxazolidine-3-carboxylate (10.0 mg, 0. 019 mmol) in EtOH (0.2 mL) and the 
resulting mixture was stirred for 4 h at 70°C. CHCl3/MeOH (7:1, 10 mL) and H2O (5 mL) were added, the 
layers were separated and the aqueous phase was extracted with CHCl3/MeOH (7:1, 2 × 10 mL). The 
combined organic extracts were dried over MgSO4 and concentrated to give the crude amine as a 
colorless solid.  
Crude 2,5-dioxopyrrolidin-1-yl (R)-2-acetoxyheneicosanoate was added to a solution of the crude amine in 
THF (0.50 mL). Et3N (3.9 mg, 0.039 mmol) was introduced and the mixture was allowed to stir at room 
temperature for 20 h. EtOAc and H2O were added, the aqueous phase was extracted with EtOAc (3 × 10 
mL), the combined organic layers were dried and concentrated to give yellow oil, which was purified by 





= +33.1 (c = 0.93, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ 8.03 (m, 2H), 7.60 (m, 1H), 
7.46 (m, 2H), 6.77 (d, J = 8.5 Hz, 1H), 5.89 (dt, J = 14.9, 6.2 Hz, 1H), 5.68-5.53 (m, 2H), 5.45-5.28 (m, 
2H), 5.17 (dd, J = 7.4, 4.6 Hz, 1H), 4.23 (ddt, J = 10.1, 6.8, 3.3 Hz, 1H), 3.77-3.63 (m, 2H), 2.73 (dd, J = 
8.2, 4.5 Hz, 1H), 2.15 (s, 3H), 2.12-2.03 (m, 4H), 1.98-1.90 (m, 2H), 1.85-1.72 (m, 2H), 1.25 (m, 48H), 
0.88 (t, J = 6.8 Hz, 6H); 
13
C NMR (100 MHz, CDCl3): δ 170.2, 169.7, 166.6, 136.8, 133.6, 131.4, 129.8, 
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129.5, 128.7, 128.6, 124.9, 74.4, 74.2, 61.6, 53.5, 32.6, 32.3, 31.94, 31.92, 31.8, 29.73 (signals 
unresolved), 29.67, 29.63, 29.57, 29.5, 29.44, 29.38, 29.36, 29.3, 29.2, 24.8, 22.7, 20.9, 14.1; IR (neat, 
cm
-1
): 3310, 2919, 2850, 1743, 1718, 1656, 1544, 1468, 1265, 1233, 1116, 1070, 966, 710; HRMS (ESI): 
m/z calcd for C48H81NO6Na [M+Na]
+
: 790.5956; found: 790.5966. 
 
Compound 21. A solution of the amide (9.0 mg, 0.012 mmol), 2,3,4,5-tetraO-benzoyl--D-glucopyranosyl 
bromide (12.9 mg, 0.020 mmol) and 4 Å MS (16.0 mg) in CH2Cl2 (0.5 mL) was stirred under Ar at room 
temperature for 30 min before it was cooled to -20°C. AgOTf (5.0 mg, 0.020 mmol) in toluene (0.1 mL) 
was added at -20°C and stirring continued at this temperature for 30 min and at 0°C for another 2 h. The 
mixture was diluted with EtOAc (10 mL) and filtered. The filtrate was extracted with EtOAc (15 mL), and 
the combined extracts were washed with aqueous NaHCO3 (5 mL), water (5 mL) and brine (5 mL). The 
combined aqueous phases were extracted with EtOAc (2 × 10 mL), the extracts were dried over MgSO4, 
filtered and concentrated. The residue was purified by preparative TLC (hexane:EtOAc = 3:1) to give the 




= +16.0 (c = 1.30, CHCl3). 
1
H NMR 
(400 MHz, CDCl3): δ 7.99 (m, 2H), 7.95 (m, 2H), 7.92 (m, 2H), 7.87 (m, 2H), 7.80 (m, 2H), 7.54-7.27 (m, 
15H), 6.47 (d, J = 9.1 Hz, 1H), 5.90-5.80 (m, 2H), 5.67-5.59 (m, 2H), 5.54-5.46 (m, 2H), 5.42-5.25 (m, 2H), 
5.01 (dd, J = 6.8, 5.2 Hz, 1H), 4.85 (d, J = 7.8 Hz, 1H), 4.51-4.43 (m, 2H), 4.31 (dd, J = 12.2, 4.9 Hz, 1H), 
4.16 (dd, J = 10.1, 3.2 Hz, 1H), 4.13-4.01 (m, 1H), 3.73 (dd, J = 10.1, 4.2 Hz, 1H), 2.01 (m, 4H), 1.92 (m, 
5H), 1.70 (m, 2H), 1.25 (m, 48H), 0.88 (t, J = 6.3 Hz, 6H); 
13
C NMR (100 MHz, CDCl3): δ 169.58, 169.55, 
166.0, 165.7, 165.2, 165.1, 165.0, 136.9, 133.42, 133.40, 133.3, 133.1, 133.0, 131.2, 130.1, 129.8, 129.7, 
129.6, 129.5, 129.0, 128.9, 128.7, 128.5, 128.38, 128.37, 128.33, 128.29, 124.8, 100.81, 74.0, 73.9, 72.9, 
72.36, 72.1, 69.5, 67.5, 62.9, 50.7, 32.6, 32.4, 31.94, 31.93, 31.87, 31.8, 29.73 (signals unresolved), 
29.68, 29.63, 29.59, 29.54, 29.46, 29.4, 29.3, 24.7, 22.7, 20.7, 14.1; IR (neat, cm
-1
): 2923, 2853, 1730, 
1689, 1602, 1515, 1452, 1266, 1095, 1027, 709; HRMS (ESI): m/z calcd for C82H107NO15Na [M+Na]
+
: 





Typhonoside F (13): NaOMe (1.0 M in methanol, 13 µL) was added to a solution of compound 21 (12.5 
mg) in MeOH (0.2 mL) and THF (0.2 mL). After 2 h, additional NaOMe (1.0 M in methanol, 3 µL) was 
added every 30 min until TLC showed complete conversion of the substrate. Stirring was continued at 5°C 
for 3 h before the reaction was neutralized with acetic acid. All volatile materials were evaporated and the 
residue was purified by flash chromatography (CH2Cl2:MeOH = 9:1 to 7:1) to give the title compound as a 




= +3.4 (c = 0.61, CHCl3:MeOH = 1:1). 
1
H NMR (400 MHz, 
[D5]-pyridine): δ 8.35 (d, J = 8.7 Hz, 1H), 7.65 (d, J = 5.1 Hz, 1H), 6.87 (d, J = 4.9 Hz, 1H), 6.38 (t, J = 6.2 
Hz, 1H), 5.99 (dd, J = 15.4, 5.8 Hz, 1H), 5.92 (dt, J = 15.5, 5.6 Hz, 1H), 5.49 (m, 2H), 4.91 (d, J = 7.6 Hz, 
1H), 4.82 (m, 1 H), 4.76 (t, J = 5.6 Hz, 1H), 4.71 (dd, J = 10.5, 5.9 Hz, 1H), 4.58 (m, 1H), 4.51 (m, 1H), 
4.36 (dt, J = 11.6, 5.7 Hz, 1H), 4.24 (dd, J = 10.5, 3.7 Hz, 1H), 4.21 (m, 2H),  4.03 (m, 1H), 3.90 (m, 1H), 
2.15 (m, 4H), 2.04-1.98 (m, 2H), 1.76 (m, 2H), 1.35-1.26 (m, 48H), 0.86 (t, J = 6.4 Hz, 3H), 0.86 (t, J = 6.4 
Hz, 3H); 
13
C NMR (100 MHz, [D5]-pyridine): δ 175.4, 131.84, 131.79, 130.9, 129.7, 105.5, 78.4, 78.2, 74.9, 
72.3, 72.1, 71.3, 70.0, 62.4, 54.4, 35.5, 32.73, 32.66, 32.5, 31.9, 29.81 (signals unresolved), 29.76, 29.75, 
29.70, 29.69, 29.65, 29.6, 29.4, 29.3, 25.7, 22.7, 14.1; IR (neat, cm
-1
): 3341, 2919, 2850, 1646, 1541, 
1468, 1080, 721; HRMS (ESI): m/z calcd for C45H84NO9 [M-H]
-
: 782.6152; found: 782.6158.  
 
tert-Butyl-(S)-4-((S,Z)-1-hydroxy-2-(tributylstannyl)hexadec-2-en-6-yn-1-yl)-2,2-dimethyloxazolidine-
3-carboxylate (25): [Cp*RuCl]4 (2.7 mg, 0.0025 mmol) was added to a solution of the diyne (86.7 mg, 
0.20 mmol) in 1,2-dichloroethane (1.0 mL) under Ar, causing a color change from brown to purple. The 
mixture was stirred at 80°C for 5 min before a solution of n-Bu3SnH (61.1 mg, 0.21 mmol) in 1,2-
dichloroethane (0.5 mL) was added via syringe pump over the course of 8 h. Once the addition was 
complete, stirring was continued for an extra 5 min. After removal of the solvent, the crude product was 
subjected to flash chromatography (hexane:EtOAc = 97:3) to give the monostannylated product as a pale 
yellow oil (72.6 mg, 50%, 71% brsm) and a second fraction of recovered starting material (17.6 mg).
10
 The 
large JSn-H value (126.4 Hz) indicated that trans-hydrostannation had occurred. [𝜶]
𝟐𝟎
𝑫  
= +1.2 (c = 1.47, 
CHCl3). 
1
H NMR (400 MHz, C6D6): δ 6.29 (t, J = 6.6 Hz, JSn-H = 126.4 Hz, 1H), 4.31 (br s, 1H), 4.18-4.06 
(m, 2H), 3.72 (dd, J = 8.8, 5.8 Hz, 1H), 2.40 (m, 2H), 2.30 (m, 2H), 2.15 (tt, J = 7.0, 2.1 Hz, 2H), 1.79-1.68 
(m, 6H), 1.67 (s, 3H), 1.54-1.46 (m, 9H), 1.38 (m, 14H), 1.27 (m, 15H), 1.01 (t, J = 7.3 Hz, 9H), 0.91 (t, J = 
6.9 Hz, 3H); 
13
C NMR (100 MHz, C6D6): δ 152.3, 147.6, 139.0, 93.5, 80.8, 80.1, 79.4, 79.1, 64.5, 60.9, 
34.1, 31.9, 29.6, 29.5 (signal unresolved), 29.4, 29.28, 29.26, 29.0, 28.1 (signals unresolved), 27.7, 24.4, 
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22.7, 19.8, 18.9, 14.0, 13.7, 11.9; 
119
Sn NMR (186 MHz, C6D6): δ -58.3; IR (neat, cm
-1
): 3495, 2955, 2923, 
2871, 2855, 1693, 1457, 1386, 1375, 1365, 1247, 1170, 1099, 1070, 1050, 871, 844; HRMS (ESI): m/z 
calcd for C38H71NO4SnNa [M+Na]
+




oxazolidine-3-carboxylate (26): A flame-dried round bottom flask was charged with Lindlar catalyst (13.0 
mg, 5% palladium to the substrate) under argon. The flask was evacuated and back filled with hydrogen 
gas from a balloon. Methanol (2.5 mL) and quinoline (15.8 mg, 0.12 mmol) were added and the resulting 
suspension was stirred for 10 min. A solution of the alkyne substrate (87.0 mg, 0.12 mmol) in MeOH (2.5 
mL) was introduced and the reaction was monitored by TLC. After 3 h, the flask was vented and the 
mixture was filtered through a pad of silica, eluting with EtOAc. The combined filtrates were evaporated 
and the crude product was purified by flash chromatography (hexane:EtOAc = 40:1) to give the title 
compound as a colorless oil (81.4 mg, 93%). [𝜶]𝟐𝟎
𝑫  
= +2.1 (c = 0.54, CHCl3). 
1
H NMR (400 MHz, C6D6): δ 
6.26 (br s, JSn-H = 127.2 Hz, 1H), 5.60-5.36 (m, 2H), 4.35 (br s, 1H), 4.19-4.06 (m, 2H), 3.72 (dd, J = 8.9, 
5.9 Hz, 1H), 2.26 (m, 4H), 2.19-2.13 (m, 2H), 1.79-1.65 (m, 9H), 1.50 (qt, J = 14.9, 7.4 Hz, 6H), 1.40 (m, 
14H), 1.30 (m, 18H), 1.01 (t, J = 7.3 Hz, 9H), 0.9- 0.88 (m, 3H); 
13
C NMR (100 MHz, C6D6): δ 152.3, 
146.6, 140.1, 130.5, 128.9, 93.5, 80.1, 79.1, 64.4, 61.0, 34.5, 32.0, 29.9, 29.7 (signals unresolved), 29.6, 
29.48, 29.45, 28.1 (signals unresolved), 27.9, 27.7, 27.5, 22.8, 14.0, 13.7, 11.9; 
119
Sn NMR (186 MHz, 
C6D6): δ -58.2; IR (neat, cm
-1
): 3501, 2954, 2922, 2853, 1693, 1615, 1455, 1386, 1249, 1171, 1099, 871; 
HRMS (ESI): m/z calcd for C38H74NO4Sn [M+H]
+
: 728.4634; found: 728.4636. 
 
tert-Butyl (S)-4-((R,2E,6E)-1-hydroxyhexadeca-2,6-dien-1-yl)-2,2-dimethyloxazolidine-3-carboxylate 
(S28): CuTC (53.4 mg, 0.28 mmol) was added to a solution of the stannane (81.4 mg, 0.11 mmol) and 
Ph2PO2NBu4 (113.1 mg, 0.25 mmol) in DMF (1.5 mL). The mixture was allowed to stir at room 
temperature for 2 h before tert-butyl methyl ether (10 mL) was added and the reaction was quenched with 
water (10 mL). The resulting yellow mixture was stirred at room temperature for an extra 30 min. The 
aqueous layer was extracted with tert-butyl methyl ether (3 × 30 mL), the combined organic layers were 
dried over MgSO4 and filtered through a pad of SiO2. Evaporation of the solvent and purification of the 
pure material by flash chromatography on silica/KF (20:1 v:v; EtOAc:hexane 20:1 to 10:1) furnished the 
title compound as a colorless liquid (44.5 mg, 91%).
2 [𝜶]𝟐𝟎
𝑫  
= -24.3 (c = 0.73, CHCl3).
 1
H NMR (400 MHz, 
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CDCl3): δ 5.68 (dt, J = 15.2 Hz, 5.6 Hz, 1H), 5.41 (dd, J = 15.2, 5.3 Hz, 1H), 5.35-5.23 (m, 2H), 4.16-3.64 
(br m, 5H), 2.07-2.00 (m, 4H), 1.93 (m, 2H), 1.42 (m, 14H), 1.19 (m, 15H), 0.81 (t, J = 6.8 Hz, 3H); 
13
C 
NMR (100 MHz, CDCl3): δ 154.2, 132.7, 130.5, 128.8, 128.6, 94.5, 81.1, 74.1, 64.9, 62.3, 32.6, 31.9, 29.7, 
29.62, 29.58, 29.4, 28.4, 27.3, 26.9, 26.3, 24.6, 22.7, 14.1; IR (neat, cm
-1
): 3453, 3006, 2956, 2925, 2854, 
1699, 1675, 1457, 1386, 1256, 1174, 1099, 1070, 965, 848, 766; HRMS (ESI): m/z calcd for C26H48NO4 
[M+H]
+
: 438.3578; found: 438.3578. 
 
tert-Butyl-(S)-4-((R,2E,6Z)-1-(benzoyloxy)hexadeca-2,6-dien-1-yl)-2,2-dimethyloxazolidine-3-
carboxylate (27): DCC (44.1 mg, 0.21 mmol) was added to a solution of the allylic alcohol (44.5 mg, 0.10 
mmol), benzoic acid (26.1 mg, 0.21 mmol) and DMAP (41.5 mg, 0.34 mmol) in CH2Cl2 (5 mL), causing the 
formation of a white precipitate. The mixture was stirred at room temperature for 24 h before the reaction 
was quenched with MeOH (0.1 mL). After stirring for an extra 15 min, the mixture was diluted with hexane 
and filtered, and the remaining solid was washed with hexane/EtOAc (25:1, 10 mL). The combined filtrates 
were concentrated and the residue was subjected to flash chromatography (EtOAc:hexane = 10:1) to 




= -35.8 (c = 0.84, CHCl3). 
1
H NMR 
(400 MHz, C6D6, rotamers): δ 8.30 (m, 2H), 7.12-7.01 (m, 3H), 6.40 (br s, 0.4H), 6.33 (br s, 0.6H), 5.89 (dt, 
J = 16.1, 6.4 Hz, 1H), 5.61-5.31 (m, 3H), 4.27 (br s, 0.4H), 4.17 (d, J = 8.8 Hz, 0.6H), 4.11 (d, J = 8.8 Hz, 
0.4H), 3.87 (br s, 0.6H), 3.79-3.66 (m, 1H), 2.09-1.87 (m, 6H), 1.70 (s, 2H), 1.55 (m, 8H), 1.39 (s, 6H), 
1.28 (m, 13H), 0.91 (t, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, C6D6, rotamers): δ 165.2, 165.1, 152.2, 151.5, 
134.5, 134.3, 132.6, 132.4, 130.6, 130.4, 129.9, 128.6, 128.4, 128.2, 126.2, 126.1, 94.7, 93.7, 79.5, 74.0, 
73.7, 63.5, 63.4, 60.3, 60.0, 32.5, 32.0, 29.8, 29.71, 29.67, 29.44, 29.38, 28.13, 27.97, 27.35, 27.22, 
26.72, 26.65, 26.31, 24.25, 22.83, 22.75, 14.01; IR (neat, cm
-1
): 3005, 2974, 2925, 2854, 1725, 1702, 





2,5-Dioxopyrrolidin-1-yl (R)-2-acetoxyheneicosanoate. DCC (5.3 mg, 0.026 mmol) was added to a 
solution of (R)-2-acetoxyheneicosanoic acid (9.1 mg, 0.024 mmol) and N-hydroxysuccinimide (3.2 mg, 
0.027 mmol) in THF (0.15 mL) at 0°C. The mixture was stirred at 0°C for 1 h and then at ambient 
temperature overnight. Water (1.5 mg, 0.08 mmol) was added and stirring continued for 1 h before the 
mixture was diluted with hexane (1 mL). The precipitated dicyclohexylurea was filtered and washed with 
hexane/EtOAc (10:1, 10 mL). The combined filtrates were dried over MgSO4, filtered and concentrated. 
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The resulting crude 2,5-dioxopyrrolidin-1-yl (R)-2-acetoxyhenicosanoate (23) was used directly in the next 
step without further purification.  
 
(2S,3R,4E,8Z)-2-((R)-2-Acetoxyhenicosanamido)-1-hydroxyoctadeca-4,8-dien-3-yl benzoate (28). aq 
HCl (2 M, 0.05 mL) was added to a stirred solution of tert-butyl-(S)-4-((R,2E,6E)-1-(benzoyloxy)hexadeca-
2,6-dien-1-yl)-2,2-dimethyl oxazolidine-3-carboxylate (10.0 mg, 0.019 mmol) in EtOH (0.2 mL) and the 
mixture was stirred for 4 h at 70°C. CHCl3/MeOH (7:1, 10 mL) and H2O (5 mL) was introduced, the layers 
were separated and the aqueous phase was extracted with CHCl3/MeOH (7:1, 2 × 10 mL). The combined 
organic extracts were dried over MgSO4 and concentrated to give the crude amine as a colorless solid.  
Crude 23 and the crude amine were dissolved in THF (0.50 mL), Et3N (3.9 mg, 0.039 mmol) was 
introduced and the resulting mixture was stirred at room temperature for 20 h. The mixture was diluted 
with EtOAc and H2O, and the aqueous layer was extracted with EtOAc (3 × 10 mL). The combined organic 
phases were dried and concentrated to give a yellow oil which was purified by flash chromatography 




= +26.7 (c = 0.27, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ 8.04 (m, 2H), 7.60 (m, 1H), 7.46 (m, 2H), 6.78 (d, 
J = 8.4 Hz, 1H), 5.90 (dt, J = 14.5, 5.9 Hz, 1H), 5.70-5.51 (m, 2H), 5.43-5.25 (m, 2H), 5.17 (dd, J = 7.5, 4.6 
Hz, 1H), 4.23 (ddt, J = 10.1, 6.8, 3.4 Hz, 1H), 3.78-3.63 (m, 2H), 2.74 (br s, 1H), 2.15 (s, 3H), 2.14-2.07 
(m, 4H), 2.02-1.94 (m, 2H), 1.88-1.69 (m, 2H), 1.25 (m, 48H), 0.88 (t, J = 6.5 Hz, 6H); 
13
C NMR (100 MHz, 
CDCl3): δ 170.2, 169.7, 166.6, 136.7, 133.6, 130.9, 129.8, 129.5, 128.6, 128.2, 125.0, 74.4, 74.2, 61.6, 
53.6, 32.4, 31.94, 31.92, 30.6, 29.72 (signals unresolved), 29.70, 29.67, 29.66, 29.62, 29.59, 29.5, 29.38, 
29.35, 29.3, 27.3, 26.5, 24.9, 22.7, 20.9, 14.1; IR (neat, cm
-1
): 3296, 2952, 2921, 2851, 1744, 1720, 1654, 
1546, 1452, 1467, 1266, 1233, 1115, 1071, 711; HRMS (ESI): m/z calcd for C48H81NO6Na [M+Na]
+
: 





Compound 29. A solution of amide 28 (9.0 mg, 0.012 mmol), 2,3,4,5-tetraO-benzoyl--D-glucopyranosyl 
bromide (12.9 mg, 0.020 mmol) and 4 Å MS (16.0 mg) in CH2Cl2 (0.5 mL) was prepared and stirred under 
Ar at room temperature for 30 min before it was cooled to -20°C. AgOTf (5.0 mg, 0.020 mmol) in toluene 
(0.1 mL) was introduced at -20°C. The mixture was stirred at -20°C for 30 min and for 2 h at 0°C before it 
was diluted with EtOAc (10 mL). Insoluble material was filtered off and rinsed with EtOAc (15 mL). The 
combined organic layers were washed with aqueous NaHCO3 solution (5 mL), water (5 mL) and brine (5 
mL). The combined aqueous phases were extracted with EtOAc (2 × 10 mL) and the combined extracts 
were dried over MgSO4, filtered and concentrated. Purification of the residue by preparative TLC 





(c = 0.21, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ 7.99 (m, 2H), 7.95 (m, 2H), 7.92 (m, 2H), 7.87 (m, 2H), 
7.80 (m, 2H), 7.54-7.27 (m, 15H), 6.47 (d, J = 9.1 Hz, 1H), 5.92-5.81 (m, 2H), 5.69-5.59 (m, 2H), 5.56-5.46 
(m, 2H), 5.39-5.24 (m, 2H), 4.99 (dd, J = 7.1, 4.9 Hz, 1H), 4.85 (d, J = 7.8 Hz, 1H), 4.53-4.43 (m, 2H), 4.33 
(dd, J = 11.6, 4.8 Hz, 1H), 4.16 (dd, J = 10.2, 3.5 Hz, 1H), 4.11 (ddd, J = 9.6, 4.9, 3.3 Hz, 1H), 3.73  (dd, J 
= 10.0, 4.4 Hz, 1H), 2.04 (m, 4H), 1.93 (m, 5H), 1.77-1.65 (m, 2H), 1.25 (m, 48H), 0.88 (t, J = 6.8 Hz, 3H), 
0.87 (t, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3): δ 169.59, 169.55, 166.0, 165.7, 165.2, 165.1, 165.0, 
136.7, 133.42, 133.39, 133.3, 133.1, 133.0, 130.7, 130.1, 129.8, 129.7, 129.6, 129.5, 129.0, 128.7, 128.5, 
128.4, 128.33, 128.29, 124.9, 100.8, 74.0, 73.8, 72.9, 72.4, 72.1, 69.5, 67.5, 62.9, 50.8, 32.4, 31.9, 31.8, 
29.73 (signals unresolved), 29.7, 29.6, 29.5, 29.37, 29.36, 27.3, 26.5, 24.7, 22.7, 20.7, 14.1; IR (neat, cm
-
1
): 2924, 2853, 1733, 1687, 1602, 1521, 1451, 1368, 1266, 1177, 1094, 1070, 709; HRMS (ESI): m/z 
calcd for C82H107NO15Na [M+Na]
+
: 1368.7533; found: 1368.7530. 
 
Typhonoside E (12): NaOMe (1.0 M in methanol, 13 µL) was added to a solution of compound 29 (12.5 
mg) in MeOH (0.2 mL) and THF (0.2 mL). After 2 h, additional NaOMe (1.0 M in methanol, 3 µL) was 
added every 30 min until TLC indicated complete conversion. The resulting mixture was then allowed to 
stir at 5°C for 3 h before the reaction was quenched with acetic acid (2.5 mg). All volatile materials were 
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removed in vacuo and the residue was purified by flash chromatography. (CH2Cl2:MeOH = 9:1 to 7:1) to 




= +2.0 (c = 0.56, CHCl3:MeOH = 
1:1). 
1
H NMR (400 MHz, [D5]-pyridine): δ 8.35 (d, J = 8.6 Hz, 1H), 7.64 (d, J = 5.0 Hz, 1H), 6.88 (d, J = 4.8 
Hz, 1H), 6.37 (t, J = 5.9 Hz, 1H), 5.99 (dd, J = 15.4, 6.0 Hz, 1H), 5.91 (dt, J = 15.4, 5.6 Hz, 1H), 5.47 (m, 
2H), 4.91 (d, J = 7.9 Hz, 1H), 4.80 (m, 1H), 4.76 (m, 1H), 4.70 (dd, J = 10.5, 5.8 Hz, 1H), 4.57 (m, 1H), 
4.50 (m, 1H), 4.35 (dt, J = 11.4, 5.6 Hz, 1H), 4.23 (dd, J = 10.6, 3.7 Hz, 1H), 4.20 (m, 2H), 4.02 (m, 1H), 
3.89 (m, 1H), 2.17 (m, 4H), 2.05-2.01 (m, 2H), 1.76 (m, 2H), 1.35-1.27 (m, 48H), 0.85 (t, J = 6.4 Hz, 3H), 
0.85 (t, J = 6.4 Hz, 3H); 
13
C NMR (100 MHz, [D5]-pyridine): δ 175.6, 132.2, 132.0, 130.6, 129.4, 105.7, 
78.6, 78.46, 75.1, 72.5, 72.3, 71.5, 70.2, 62.6, 54.6, 35.7, 32.9, 32.1, 30.02, 29.98, 29.97, 29.91, 29.88, 
29.6, 27.6, 27.3, 25.9, 22.9, 14.3; IR (neat, cm
-1
): 3336, 2959, 2920, 2851, 1641, 1534, 1466, 1377, 1260, 
1076, 799; HRMS (ESI): m/z calcd for C45H84NO9 [M-H]
-
: 782.6152; found: 782.6156. 
 
tert-Butyl-(S)-4-((S,Z)-2-fluoro-1-hydroxyhexadec-2-en-6-yn-1-yl)-2,2-dimethyloxazolidine-3-
carboxylate (31): A flame-dried Schlenk tube was charged with a stir bar, solid silver diphenylphosphinate 
(13.0 mg, 0.04 mmol) and F-TEDA-PF6 (11.3 mg, 0.024 mmol). The mixture was stirred under Argon for 
10 min to form a homogenous grey powder which was then suspended in anhydrous acetone (0.3 mL). A 
solution of the stannane (14.5 mg, 0.02 mmol) in anhydrous acetone (0.4 mL) was added dropwise over 1 
h. The reaction mixture was quenched with sat. NH4Cl (5 mL) and tert-butyl methyl ether (5 mL), the 
aqueous phase was extracted with tert-butyl methyl ether (3 times, 10 mL each). The combined organic 
layers were washed with brine (10 mL), dried over MgSO4, filtered and concentrated. The residue was 
purified by flash chromatography (tert-butyl methyl ether:hexane = 1:10) followed by preparative HPLC 
(MeOH:water = 90:10) to give the fluoroalkene as a pale yellow oil (4.5 mg, 50%). [𝜶]𝟐𝟎
𝑫  
= -16.0 (c = 0.44, 
CHCl3). 
1
H NMR (500 MHz, [D6]-Benzene, 343 K): δ 5.06 (dt, J = 37.7, 7.4 Hz, 1H), 4.39 (t, J = 10.3, 7.0 
Hz, 1H), 4.15-4.01 (m, 1H), 3.95 (s, 1H), 3.64 (dd, J = 9.3, 6.7 Hz, 1H), 2.40-2.25 (m, 2H), 2.19-2.14 (m, 
2H), 2.14-2.08 (m, 2H), 1.63 (s, 3H), 1.48 (p, J = 7.1 Hz, 2H), 1.44 (s, 3H), 1.40 (s, 9H), 1.38-1.22 (m, 
12H), 0.90 (t, J = 6.7 Hz, 3H); 
13
C NMR (126 MHz, [D6]-Benzene, 343 K): δ 158.6 (d, J = 258.4 Hz), 105.8 
(d, J = 11.9 Hz), 94.3, 80.8, 79.9, 79.1, 71.0 (d, J = 32.0 Hz), 63.9 (signals unresolved), 31.8, 29.5, 29.21, 
29.15, 29.1, 28.8, 28.0 (signals unresolved), 26.2, 23.5 (d, J = 4.6 Hz), 22.6, 18.9 (d, J = 2.0 Hz), 18.8, 
13.7; 
19
F NMR (470 MHz, [D6]-Benzene, 280 K): δ -119.4 (dd, J = 37.3, 9.9 Hz, major rotamer), -122.4 (dd, 
J = 37.6, 9.1 Hz, minor rotamer). IR (neat, cm
-1
): 3460, 2927, 2856, 1703, 1456, 1387, 1366, 1257, 1173, 
1092, 848; HRMS (ESI): m/z calcd for C26H44NO4FNa [M+Na]
+


















 Δδ (ppm) 
1 4.71 (dd, 10.8, 6.0) 4.70 (dd, 10.5, 5.8) 0.01 
4.24 (dd, 10.8, 4.4) 4.23 (dd, 10.6, 3.7) 0.01 
2 4.80 (m) 4.80 (m) - 
3 4.76 (t, 6.0) 4.76 (m) - 
4 5.99 (dd, 15.3, 6.6) 5.99 (dd, 15.4, 6.0) - 
5 5.92 (dt, 15.3, 6.6) 5.91 (dt, 15.4, 5.6) 0.01 
6 2.16 (m) 2.17 (m) 0.01 
7 2.03 (m) 2.01-2.05 - 
8 5.47 (m) 5.47 (m) - 
9 5.46 (m) 5.47 (m) 0.01 
10 2.18 (m) 2.17 (m) 0.01 
11-15 1.24-1.36 (m)  1.27-1.35 (m) - 
16 1.27 (m) 1.27-1.35 (m) - 
17 1.27 (m) 1.27-1.35 (m) - 
18 0.85 (t, 6.6) 0.85 (t, 6.4) - 
1’    
2’ 4.56 (m) 4.57 (m) 0.01 
3’ 2.01 (m) 2.01-2.05 - 
4’ 1.78 (m) 1.76 (m) 0.02 
5’-18’ 1.24-1.36 (m) 1.27-1.35 (m) - 
19’ 1.27 (m) 1.27-1.35 (m) - 
20’ 1.27 (m) 1.27-1.35 (m) - 
21’ 0.85 (t, 6.6) 0.85 (t, 6.4) - 
1” 4.91 (d, 7.8) 4.91 (d, 7.9) - 
2” 4.02 (m) 4.02 (m) - 
3” 4.22 (m) 4.20 (m) 0.02 
4” 4.21 (m) 4.20 (m) 0.01 
5” 3.89 (m) 3.89 (m) - 
6” 4.50 (m) 4.50 (m) - 
 4.34 (dd, 11.7, 5.4) 4.35 (dt, 11.4, 5.6) 0.01 
N-H 8.35 (d, 9.0) 8.35 (d, 8.6) - 
 - 7.64 (d, 5.0) - 
unassigned signals
c
 - 6.68 (d, 4.8) - 
(-OH) - 6.37 (d, 5.9) - 
a
Data were recorded at 600 MHz. 
b
Data were recorded at 400 MHz. 
c
These signals were found on the original spectrum but not 
















 Δδ (ppm) 
1 70.1 70.2 0.1 
   
2 54.6 54.6 - 
3 72.3 72.3 - 
4 132.2 132.2 - 
5 132.1 132.0 0.1 
6 32.9 32.9 - 
7 27.6 27.6 - 
8 130.6 130.6 - 
9 129.4 129.4 - 
10 27.3 27.3 - 
11-15 29.6-30.0 29.6-30.0 - 
16 32.1 32.1 - 
17 22.9 22.9 - 
18 14.3 14.3 - 
1’ 175.6 175.6 - 
2’ 72.5 72.5 - 
3’ 35.6 35.7 0.1 
4’ 25.9 25.9 - 
5’-18’ 29.6-30.0 29.6-30.0 - 
19’ 32.1 32.1 - 
20’ 22.9 22.9 - 
21’ 14.2 14.3 0.1 
1” 105.7 105.7 - 
2” 75.1 75.1 - 
3” 78.4 78.5 0.1 
4” 71.5 71.5 - 
5” 78.6 78.6 - 
6” 62.6 62.6 - 
a
Data were recorded at 600 MHz. 
b


















 Δδ (ppm) 
1 4.71 (dd, 10.2, 6.0) 4.71 (dd, 10.5, 5.9) - 
4.25 (dd, 10.8, 4.2) 4.24 (dd, 10.5, 3.7) 0.01 
2 4.82 (m) 4.82 (m) - 
3 4.76 (t, 6.0) 4.76 (t, 5.6) - 
4 5.99 (15.6, 6.0) 5.99 (dd, 15.4, 5.8) - 
5 5.92 (dt, 15.6, 6.0) 5.92 (dt, 15.5, 5.6) - 
6 2.17 (m) 2.15 (m) 0.02 
7 2.06 (m) 1.98-2.04 (m) 0.02 
8 5.50 (m) 5.49 (m) - 
9 5.50 (m) 5.49 (m) - 
10 2.14 (m) 21.5 (m) 0.01 
11-15 1.24-1.36 (m) 1.26-1.35 (m) - 
16 1.27 (m) 1.26-1.35 (m) - 
17 1.27 (m) 1.26-1.35 (m) - 
18 0.86 (t, 6.6) 0.86 (t, 6.4) - 
1’    
2’ 4.58 (m) 4.58 (m) - 
3’ 2.02 (m) 1.98-2.04 (m) - 
4’ 1.78 (m) 1.76 (m) - 
5’-18’ 1.24-1.36 (m) 1.26-1.35 (m) - 
19’ 1.27 (m) 1.26-1.35 (m) - 
20’ 1.27 (m) 1.26-1.35 (m) - 
21’ 0.86 (t, 6.6) 0.86 (t, 6.4) - 
1” 4.92 (7.8) 4.91 (d, 7.6) 0.01 
2” 4.02 (m) 4.03 (m) - 
3” 4.21 (m) 4.21 (m) - 
4” 4.21 (m) 4.21 (m) - 
5” 3.90 (m) 3.90 (m)  
6” 4.51 (m) 4.51 (m) - 
 4.36 (dd, 11.4, 5.4) 4.36 (dt, 11.6, 5.7) - 
N-H 8.36 (d, 9.0) 8.35 (d, 8.7) 0.01 
 - 7.65 (d, 5.1) - 
Unassigned signals
c
 - 6.87 (d, 4.9) - 
(-OH) - 6.38 (d, 6.2) - 
a
Data were recorded at 600 MHz. 
b
Data were recorded at 400 MHz. 
c
These signals were found on the original spectrum but not 















 Δδ (ppm) 
1 69.9 70.0 0.1 
   
2 54.3 54.4 0.1 
3 72.1 72.1 - 
4 131.9 131.84 0.04 
5 131.8 131.8 - 
6 32.7 32.7 - 
7 32.7 32.7 - 
8 129.7 129.7 - 
9 130.9 130.9 - 
10 32.5 32.5 - 
11-15 29.3-29.9 29.3-29.8 - 
16 31.9 31.9 - 
17 22.7 22.7 - 
18 14.1 14.1 - 
1’ 175.4 175.4 - 
2’ 72.3 72.3 - 
3’ 35.4 35.5 0.1 
4’ 25.7 25.7 - 
5’-18’ 29.3-29.9 29.3-29.8 0.1 
19’ 31.9 31.9 - 
20’ 22.7 22.7 - 
21’ 14.1 14.1 - 
1” 105.4 105.5 - 
2” 74.9 74.9 - 
3” 78.2 78.2 - 
4” 71.3 71.3 - 
5” 78.4 78.4 - 
6” 62.4 62.4 - 
a
Data were recorded at 600 MHz. 
b
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NMR spectra of 31. 
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